%PDF-1.3
%
3 0 obj
<>>>/BBox[0 0 612 792]/Length 140>>stream
x0E>uHDYt|b0!mI[{;(=$.=; јv5^dEXcp(pļnTEk
1D&bK~٧b-M
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 140>>stream
x0E>uHDYt|b0!mI[{;(=$.=; јv5^dEXcp(pļnTEk
1D&bK~٧b-M
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 140>>stream
x0E>uHDYt|b0!mI[{;(=$.=; јv5^dEXcp(pļnTEk
1D&bK~٧b-M
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 140>>stream
x0E>uHDYt|b0!mI[{;(=$.=; јv5^dEXcp(pļnTEk
1D&bK~٧b-M
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 140>>stream
x0E>uHDYt|b0!mI[{;(=$.=; јv5^dEXcp(pļnTEk
1D&bK~٧b-M
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 140>>stream
x0E>uHDYt|b0!mI[{;(=$.=; јv5^dEXcp(pļnTEk
1D&bK~٧b-M
endstream
endobj
9 0 obj
<>stream
Arbortext Advanced Print Publisher 9.0.114/W
2020-08-13T05:06:42-07:00
2020-07-31T20:17:31+05:30
application/pdf
JPM-2020-0249-ver9-Strang_2P 1..6
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
uuid:e8e31330-32c7-434e-a258-e83027cc3f46
uuid:0e904e53-63d6-44a2-9093-91e68eb36406
endstream
endobj
10 0 obj
<>stream
x+ |
endstream
endobj
11 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
12 0 obj
<>stream
x+ |
endstream
endobj
13 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
14 0 obj
<>stream
x+ |
endstream
endobj
15 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
23 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 62.022 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(hospital)-269.4(and)-269.4(ICU)-270.1(were)-272.5(56)]TJ
7.3823 0 0 6.5614 164.0125 729.5242 Tm
(3)Tj
9.843 0 0 9.843 170.3621 725.1588 Tm
[(and)-269.4(47)-267.1(years,)]TJ
7.3823 0 0 6.5614 222.9732 729.5242 Tm
(1)Tj
9.843 0 0 9.843 229.3228 725.1588 Tm
-.0225 Tc
[(respecti)5.1(vel)5.1(y)-.6(.)-267.8(I)5.2(n)-271.3(t)5.1(he)]TJ
-16.9969 -1.1174 TD
-.0214 Tc
[(re)5.1(cen)6.3(t)-224.2(N)5.4(ew)-225(Y)5.4(o).5(rk)-218.3(st)6.2(udy)6.3(,)-226.4(m)5.1(ed)6.3(ian)-218.3(a)-.6(g)6.3(e)-225.2(a)5.1(t)-224.2(ad)6.3(mi)6.2(ssio)6.3(n)-224.1(w)5.4(a)-.6(s)-223.9(6)6.3(3)-224.1(y)6.3(ear)6.3(s.)]TJ
7.3823 0 0 6.5614 297.4109 718.5825 Tm
0 Tc
(2)Tj
9.843 0 0 9.843 62.022 703.2188 Tm
-.0213 Tc
[(Ho)6.4(wev)6.4(e)-.5(r,)-514.3(e)5.2(m)-.6(e)5.2(r).7(gi)6.3(ng)-517.7(s)6.6(t).5(at)6.3(ist)6.3(i).5(cs)-511.8(sho)6.4(w)-518.6(t)6.3(h).6(at)-512.1(wh)6.4(en)-517.7(a)5.2(l).5(l)-512.1(d).6(ea)5.2(ths)-511.8(i).5(n)]TJ
0 -1.1116 TD
-.0223 Tc
[(COVID-19)-230.7(are)-231.9(c)-1.5(on)5.4(sid)5.4(e)-1.5(red,)-233.1(the)-231.9(m)-1.6(ea)]TJ
13.495 0 TD
[(n)-236.5(a)-1.5(g)5.4(e)-237.7(is)-230.5(sub)5.4(s)-.2(tan)5.4(tiall)5.3(y)-236.5(h)-.4(ig)5.4(her.)]TJ
-13.495 -1.1116 TD
-.022 Tc
[(Recen)5.7(t)-265.1(d)-.1(at)5.6(a)-266.2(i)-.2(nd)5.7(icate)-266.2(t)5.6(hat)-265.1(a)4.5(bou)5.7(t)-265.1(40)5.7(50%)-266.1(o)5.7(f)-265(deaths)-264.8(o)5.7(ccu)5.7(r)-265(a)-1.2(mong)]TJ
0 -1.1174 TD
-.0222 Tc
[(el)5.4(der)5.5(l)-.4(y)-305.5(p)-.3(eopl)5.4(e)-306.7(i)-.4(n)-305.5(n)5.5(urs)5.7(i)-.4(ng)-305.5(h)5.5(o)-.3(mes,)]TJ
7.3823 0 0 6.5614 186.7464 674.7021 Tm
0 Tc
(4)Tj
9.843 0 0 9.843 193.2094 670.3369 Tm
-.0217 Tc
[(but)-305.2(l)5.9(itt)5.9(le)-306.2(i)5.9(s)-304.8(kno)6(wn)-305(ab)6(out)-299.4(the)]TJ
-13.328 -1.1116 TD
-.022 Tc
[(way)-288(t)-.2(h)5.7(e)-1.2(y)-288(d)5.7(ie.)-284.6(I)0(n)-282.3(S).1(weden)5.7(,)-290.4(p)5.7(e)-1.2(op)5.7(le)-289.2(r)5.7(e)-1.2(si)5.6(din)5.7(g)-288(at)-282.4(nur)5.7(sing)-282.3(homes)-282.1(are)]TJ
T*
[(frail)-282.4(and)-282.3(e)-1.2(l)5.6(d)-.1(er)5.7(ly,)-284.6(w)4.8(ith)-282.3(sev)5.7(e)-1.2(ral)-288.2(c)4.5(hro)5.7(n)-.1(ic)-283.4(co)5.7(mor)5.7(b)-.1(id)5.7(iti)5.6(es)-287.8(and)-282.3(w)-.9(it)5.6(h)-288(a)]TJ
0 -1.1174 TD
-.0224 Tc
[(hi)5.2(gh)-369.1(need)-374.8(o)5.3(f)-374.8(daily)-369.1(su)5.3(ppo)5.3(rt)-369.2(and)-369.1(a)-1.6(t)5.2(t)-.6(en)5.3(dan)5.3(ce,)-371.4(whereas)-374.6(p)-.5(all)5.2(i)-.6(at)5.2(ive)]TJ
0 -1.1116 TD
-.0215 Tc
[(ca)5(re)-346.3(pa)5(tie)5(nts)-344.9(w)-.4(i)6.1(t).3(h)-345.1(c)-.7(o)6.2(m)-.8(p)6.2(l).3(ex)-345.1(sy)6.2(mp)6.2(tom)5(s)-350.7(a)5(n).4(d)-345.1(s).6(u)6.2(b).4(st)6.1(ant)6.1(i).3(al)]TJ
/F6 1 Tf
21.2591 0 TD
[(me)5(di)6.1(cal)]TJ
/F5 1 Tf
-21.2591 -1.1116 TD
[(ne)5.1(eds)-258.4(a)-.6(r)6.3(e)-265.6(c)5.1(a)-.6(re)5.1(d)-264.4(f).6(o)6.3(r)-264.4(i)6.2(n)-264.4(s)6.5(p).5(ec)5.1(ial)6.2(i).4(ze)5.1(d)-264.4(p)6.3(all)6.2(i).4(at)6.2(ive)-259.8(c)-.6(a)5.1(r).6(e)-259.8(s).7(er)6.3(vic)5.1(e)-.6(s.)-261(T)5.1(h).5(u)6.3(s).7(,)]TJ
0 -1.1174 TD
-.0219 Tc
[(Swedi)5.7(s).2(h)-253.4(n)5.8(urs)6(i)-.1(ng)-247.6(homes)-247.4(con)5.8(s).2(ti)5.7(tut)5.7(e)-254.5(a)-248.8(f).1(or)5.8(m)-254.6(o)5.8(f)-253.4(l)-.1(o)5.8(ng-)5.8(ter)5.8(m)-254.6(f)5.8(aci)5.7(lit)5.7(ies)]TJ
0 -1.1116 TD
-.0221 Tc
[(fo)5.6(r)-397.5(p)5.6(ers)5.8(ons)-391.6(needi)5.5(n)-.2(g)-391.8(m)-1.4(u)5.6(c)-1.3(h)-391.8(h)-.2(elp)-391.8(w)-1(it)5.5(h)-391.8(act)5.5(ivi)5.5(ties)-397.4(o)5.6(f)-397.5(d)5.6(ail)5.5(y)-391.8(liv)5.6(ing)]TJ
T*
-.0223 Tc
[(fu)5.4(nct)5.3(i)-.5(on)5.4(s.)-538.3(Mor)5.4(e)-1.5(o)5.4(v)-.4(er)5.4(,)-544.1(6)5.4(07)5.4(0%)-537.1(are)-537.2(e)-1.5(s)5.6(timated)-541.8(t)5.3(o)-541.8(su)5.4(ffer)-541.7(f)-.3(r)5.4(o)-.4(m)]TJ
T*
[(co)5.3(gni)5.2(tiv)5.3(e)-191.7(f)-.4(ai)5.2(lur)5.3(e)-191.7(or)-190.5(are)-191.7(d)-.5(i)5.2(a)-1.6(gn)5.3(osed)-190.5(wit)5.2(h)-190.5(demen)5.3(tia.)-192.9(F)-.3(o)5.3(r)-190.5(th)5.3(is)-190.3(reason)5.3(,)]TJ
0 -1.1174 TD
[(Swedi)5.2(s)-.3(h)-374.8(nurs)5.5(i)-.6(ng)-374.8(ho)5.3(mes)-380.4(a)4.1(re)-376(ver)5.3(y)-380.6(d)5.3(i)-.6(ff)5.3(erent)-375(from)-376.1(o)5.3(ther)-380.6(acco)5.3(m-)]TJ
0 -1.1116 TD
-.0221 Tc
[(mo)5.6(dat)5.5(i)-.3(on)5.6(s)-299.5(f)5.6(or)-299.6(r)5.6(e)-1.3(ti)5.5(red)-293.9(p)-.2(erso)5.6(ns,)-296.2(f)5.6(or)-299.6(exampl)5.5(e,)-296.2()51.7()-.1(6)5.6(5)]TJ
/F7 1 Tf
18.4944 0 TD
0 Tc
(+)Tj
/F5 1 Tf
.8236 0 TD
-.021 Tc
[(ac)5.5(com)5.5(m)-.3(o)6.7(d).9(a-)]TJ
-19.3181 -1.1116 TD
-.022 Tc
[(ti)5.6(ons)57.6()-218.9(f)5.7(o)-.1(r)-213.1(h)-.1(ealth)5.7(y)-213.2(e)-1.2(ld)5.7(erl)5.6(y)-218.9(p)5.7(e)-1.2(o)5.7(p)-.1(le)-214.3(wh)5.7(o)-213.2(lik)5.7(e)-220.1(t)5.6(he)-214.3(po)5.7(ssib)5.7(ili)5.6(ty)-213.2(to)-213.2(have)]TJ
0 -1.1174 TD
-.0212 Tc
[(ac)5.3(ces)6.7(s)-385(t).6(o)-379.4(s).9(o)6.5(c)-.4(ia)5.3(l)-385.3(a)5.3(cti)6.4(v).7(it)6.4(ies)6.7(,)-387.5(c)5.3(o).7(m)5.3(m)-.5(u)6.5(n).7(al)-379.5(res)6.7(t).6(au)6.5(ran)6.5(t)-385.3(f)6.5(aci)6.4(lit)6.4(ies)6.7(,)-381.7(and)]TJ
0 -1.1116 TD
[(co)6.4(mm)5.2(on)-275.8(soc)5.2(i).5(al)-276(ar)6.4(ea)5.2(s)-281.4(i).5(n)-275.8(a)5.2(dju)6.4(n).6(ct)6.3(ion)-275.8(t).5(o)-275.8(t).5(h)6.4(e)-.5(ir)-275.8(a)5.2(p).6(ar)6.4(tme)5.2(n).6(t.)]TJ
1.0137 -1.1116 TD
-.0157 Tc
[(In)-270.2(2019)-15.7(,)-256.4(t).4(he)-271.4(media)-15.7(n)-255.2(p).5(er)-15.7(i)10.8(o).5(d)-270.2(o).5(f)-270.2(care)-271.4(from)-271.4(admi)-15.7(s)11(s).7(io)-15.7(n)-254(t).4(o)-270.2(d).5(ea)-15.7(t)9.6(h)]TJ
-1.0137 -1.1174 TD
-.0152 Tc
(was)Tj
/F7 1 Tf
1.7106 0 TD
0 Tc
(<)Tj
/F5 1 Tf
.5357 0 TD
-.0155 Tc
[(2)-200.9(y).7(ear)-15.5(s)-190.3(i).6(n)-200.9(nur)-15.5(s)11.3(i).6(n)-15.5(g)-190.5(homes)-200.7(an)-15.5(d)-190.5(t).6(he)-202.1(med)-15.5(i)11(a)-.5(n)-200.9(a)-.5(ge)-202.1(a)-15.5(t)-191.8(death)-200.9(w)-15.5(a)9.1(s)]TJ
-2.2463 -1.1116 TD
-.0159 Tc
[(abo)-15.9(u)10.7(t)-293.6(8).3(6)-287.7(y)-15.9(e)9.5(a)-.9(rs)-15.9(.)-279.4(G)-.6(ener)-15.9(a)9.6(lly)-15.9(,)-279.6(a)-.9(n)-293.5(a)-.9(dmis)-15.9(s)11.1(i).2(on)-293.5(to)-293.5(a)-288.9(S).4(w)-15.9(e)8.7(dis)-15.9(h)-277.1(nu)-15.9(r)10.7(s).5(i)-15.9(n)10.6(g)]TJ
T*
[(ho)-15.9(m)9.5(e)-271.6(is)-270.2(ap)-15.9(p)10.7(rove)-15.9(d)-261.2(only)-276.2(i).2(f)-270.4(s).5(i)-15.9(x)-260.1(to)-270.4(eig)-15.9(h)10.7(t)-270.6(hom)-15.9(e)-262.4(h).3(elp)-270.4(v)-15.9(i)10.6(s).5(it)-15.9(s)-259.9(p).3(er)-270.4(d)-15.9(a)9.5(y)]TJ
0 -1.1174 TD
[(ar)-15.9(e)-284.2(not)-293.6(e)-15.9(n)9.5(ough)-299.2(for)-293.4(a)-294.6(p)-15.9(e)9.5(r).3(so)-15.9(n)-283(t).2(o)-293.5(r)-15.9(e)9.6(s).5(id)-15.9(e)-284.2(i).2(n)-293.5(h).3(i)-15.9(s)-283(or)-293.4(he)-15.9(r)-284.2(o).3(wn)-293.5(h)-15.9(o)10.7(me.)]TJ
0 -1.1116 TD
[(Fo)-16(r)-438.6(t).1(his)-448.9(r)-16(e)9.5(a)-1(so)-16(n)10.6(,)-445.6(t)-16(h)10.5(e)-450.2(popu)-16(l)10.5(a)-1(tio)-16(n)-438.7(dyin)-16(g)-438.7(due)-450.2(to)-449.1(COV)-16(I)9.8(D-1)-16(9)-438.7(at)]TJ
T*
-.0158 Tc
[(ho)-15.8(s)11(p).4(it)-15.8(a)9.5(l).3(s)-218.3(a)-15.8(n)9.6(d)-218.5(nur)-15.8(s)11(i).3(n)-15.8(g)-208.1(homes)-224.1(are)-225.4(d).4(iff)-15.8(e)9.7(rent)-224.4(at)-218.6(le)-15.8(a)8.5(s).6(t)-218.6(r)-15.8(e)9.7(g).4(ard)-15.8(i)10.7(ng)-218.5(a)-15.8(g)9.6(e)]TJ
T*
0 Tc
[(a)15(n)16.2(d)-415.8(f)16.2(ra)25.5(i)16.1(l)16.1(t)0(y)26.5(.)-412.4(M)15.3(o)16.2(re)25.5(o)16.2(v)16.2(e)15(r,)-401.9(S)16.3(w)15.3(ed)25.4(i)16.1(s)16.4(h)-415.8(h)16.2(o)16.2(s)0(p)26.8(i)16.1(ta)25.3(l)16.1(s)-415.6(a)15(r)16.2(e)-417(m)15(a)15(i)16.1(n)16.2(l)0(y)-399.7(s)0(t)26.7(a)15(f)16.2(f)0(e)25.5(d)]TJ
0 -1.1174 TD
-.0157 Tc
[(wi)-15.7(t)10.6(h)-345.1(phys)-15.7(i)11(c)-.7(ia)-15.7(n)9.7(s)-344.9(and)-345.1(r).5(e)-15.7(g)9.7(ist)-15.7(e)9.6(red)-345.1(n).5(u)-15.7(r)10.9(ses)-15.7(,)-331.1(wh)-15.7(e)9.7(r).5(eas)-344.9(t)-15.7(h)10.8(e)-346.3(grea)-15.7(t)-330.2(m)-15.7(a)8.5(-)]TJ
0 -1.1116 TD
-.016 Tc
[(jo)-16(r)10.6(ity)-368.4(of)-368.4(th)-16(e)-353.4(s)-16(t)10.7(a)-1(ff)-368.4(i)-16(n)-352.4(n)-16(u)10.6(rsi)-16(n)10.5(g)-368.4(homes)-368.2(\()]TJ
/F7 1 Tf
14.8543 0 TD
0 Tc
(>)Tj
/F5 1 Tf
.5357 0 TD
[(9)16.2(0)16.2(%)15.1(\))-352.4(c)15(on)26.6(s)16.4(t)16.1(it)26.3(u)16.2(t)16.1(e)-353.6(o)16.2(f)-352.4(a)15(s-)]TJ
-15.3899 -1.1116 TD
-.0159 Tc
[(si)-15.9(s)10.8(t).2(an)-15.9(t)-381.1(nur)-15.9(s)10.9(e)-.9(s)-391.2(a)-.9(n)-15.9(d)-381(onl)-15.9(y)-381.1(t).2(o)-391.4(a)-392.5(min)-15.9(o)10.7(r)-391.3(p).3(ar)-15.9(t)-381.1(o).3(f)-391.3(r)-15.9(e)9.6(g).3(is)-15.9(t)10.8(e)-.9(red)-397.1(nurs)-15.9(e)9.7(s).5(.)]TJ
0 -1.1174 TD
-.0158 Tc
[(Ph)-15.8(y)10.8(s).6(ic)-15.8(i)9.5(a)-.8(ns)-235.6(ar)-15.8(e)-220.7(n)-15.8(o)10.8(t)-235.9(dire)-15.8(c)8.5(tly)-235.8(empl)-15.8(o)10.7(yed)-235.8(b).4(y)-235.8(t).3(h)-15.8(e)-220.8(n)-15.8(u)10.8(rsi)-15.8(n)10.7(g)-235.8(homes)-235.6(b)-15.8(u)10.8(t)]TJ
0 -1.1116 TD
-.0159 Tc
[(con)-15.9(s)10.9(ti)-15.9(t)10.4(u).3(te)-260.1(a)-260.1(\().3(sc)-15.9(a)8.4(r).3(ce\))-258.9(r)-15.9(e)9.6(sou)-15.9(r)10.7(ce)-260.1(prov)-15.9(i)10.6(d).3(ed)-258.9(by)-258.9(th)-15.9(e)-243.9(c)-15.9(o)9.5(unt)-15.9(y)-242.9(c)-15.9(o)9.5(unci)-15.9(l)10.4(s.)]TJ
1.0137 -1.1116 TD
0 Tc
[(In)-393.8(Swedish)-389.7(health)-395.1(care,)-397.2(there)-393.8(have)-392.6(been)-398.4(efforts)-394.6(to)-388.2(safe-)]TJ
-1.0137 -1.1174 TD
[(guard)-288.9(the)-286.8(quality)-285.7(of)-290.2(care)-290.1(for)-285.5(dying)-287.9(people,)-289(which)-284.1(have)-289(been)]TJ
0 -1.1116 TD
[(previously)-450(described.)]TJ
7.3823 0 0 6.5614 148.3086 345.9401 Tm
(5)Tj
9.843 0 0 9.843 156.4157 341.5747 Tm
[(The)-443.4(Swedish)-447.3(Register)-449.9(of)-439.9(Palliative)]TJ
-9.5899 -1.1116 TD
[(Care)-462.7(\(SRPC\),)-461(a)-457.3(nationwide)-463.9(quality)-458.5(register)-460.4(of)-457.2(end-of-life)]TJ
T*
[(\(EOL\))-296.7(care,)-299.3(encourages)-303.4(all)-298.5(county)-295.9(councils)-299.2(and)-298.2(municipali-)]TJ
0 -1.1174 TD
[(ties)-380(in)-382.5(Sweden)-378.3(to)-382.5(retrospectively)-384.3(complete)-382.4(a)-382.4(questionnaire)]TJ
0 -1.1116 TD
[(about)-271.8(EOL)-271.5(care)-278.6(with)-270.5(focus)-271.4(on)-272.9(last)-270.6(week)-272.5(of)-272.9(life.)-274.2(The)-270.6(register)]TJ
T*
[(provides)-309.4(EOL)-306.1(data)-306.4(and)-304(allows)-308.2(comparisons)-309.1(across)-308(different)]TJ
0 -1.1174 TD
[(care)-249.8(settings.)-243.8(So)-243.9(far,)-249.7(30)-244.1(peer-reviewed)-251.4(publications)-246.3(based)-249.5(on)]TJ
0 -1.1116 TD
[(SRPC)-501.5(data)-502.2(have)-502.1(been)-502.1(published.)-504.2(Owing)-497(to)-503.4(a)-497.6(reasonable)]TJ
T*
[(coverage)-330.2(\()]TJ
/F10 1 Tf
4.2852 0 TD
(*)Tj
/F5 1 Tf
1.0022 0 TD
[(60%)-326.9(of)-324.7(all)-327.3(deaths)-325.7(in)-330.6(the)-327.1(country\),)-324.5(some)-329.1(of)-324.7(the)]TJ
-5.2874 -1.1174 TD
[(questions)-391.1(retrieved)-399.5(from)-391.5(the)-390.5(SRPC)-392(have)-392.6(even)-392.6(become)-391.5(na-)]TJ
0 -1.1116 TD
[(tional)-232.8(quality)-233.9(indicators)-238.1(for)-227.9(a)-232.6(good)-234.8(death)-232.6(in)-232.7(Sweden,)-232(adopted)]TJ
T*
[(by)-278.7(the)-281.1(National)-288.9(Board)-278.4(of)-284.4(Health)-280.8(and)-280.9(Welfare.)]TJ
7.3823 0 0 6.5614 244.5732 225.411 Tm
(6)Tj
/F3 1 Tf
8.9663 0 0 8.9663 62.022 199.0488 Tm
(Aims)Tj
/F5 1 Tf
9.843 0 0 9.843 72 182.6078 Tm
-.0159 Tc
[(Th)-15.9(e)-249.6(a)-15.9(i)9.4(m)-265.9(of)-264.6(th)-15.9(e)-249.7(s)-15.9(t)10.8(u)-15.9(d)10.7(y)-264.7(wa)-15.9(s)-249.5(t)-15.9(o)-254.4(e)-.9(xa)-15.9(m)8.3(i).2(n)-15.9(e)-255.4(sym)-15.9(p)9.5(to)-15.9(m)-255.5(c)-.9(on)-15.9(t)10.6(r)-15.9(o)10.7(l)-264.8(dat)-15.9(a)]TJ
-1.0137 -1.1116 TD
0 Tc
[(o)16.2(n)-513.7(al)25.3(l)-513.8(r)0(e)25.5(p)16.2(or)26.6(te)25.3(d)-513.7(C)15.2(O)15.3(V)0(I)25.8(D)0(-)25.8(1)0(9)26.6(-)16.2(re)25.5(la)25.3(t)16.1(e)0(d)-504.5(d)16.2(e)15(a)0(t)25.3(h)16.2(s)-513.5(i)0(n)-503.4(h)16.2(os)26.8(p)16.2(i)0(t)26.3(a)0(l)25.3(s)-513.5(a)15(n)0(d)]TJ
T*
[(n)16.2(u)0(r)26.6(s)0(i)26.7(n)0(g)-342(h)0(o)26.6(m)15(es)-343(\(d)26.6(at)25.3(a)-359.4(s)16.4(et)-343.3(re)25.5(t)16.1(r)0(i)26.5(e)0(v)25.4(e)15(d)-358.2(A)15.3(pr)26.6(il)-342.3(24)26.6(,)-354.8(2)0(0)26.6(2)0(0)26.6(\))16.2(,)-360.5(u)16.2(si)26.7(n)16.2(g)-358.2(t)16.1(h)0(e)]TJ
T*
[(SR)25.7(P)16.3(C)0(,)-351.1(a)-359.4(va)25.4(l)16.1(i)0(d)26.5(a)0(t)25.3(e)15(d)-364(n)16.2(at)25.3(io)26.5(n)16.2(a)0(l)-349.1(q)0(u)26.6(a)15(li)26.3(ty)-347.9(re)25.5(g)16.2(i)0(s)26.7(t)0(e)25.3(r)0(.)]TJ
7.3823 0 0 6.5614 233.8015 154.148 Tm
-.0239 Tc
[(5,)-23.9(7)]TJ
9.843 0 0 9.843 246.3306 149.7826 Tm
0 Tc
[(A)-359.1(f)0(u)26.6(r)16.2(th)26.5(er)-348.9(ai)25.3(m)]TJ
-18.7248 -1.1174 TD
[(w)15.3(a)0(s)-406.3(t)16.1(o)-415.8(c)15(o)16.2(m)0(p)25.4(a)15(re)-400.7(oc)25.4(cu)25.4(r)16.2(r)0(e)25.5(n)0(c)25.4(e)-417(o)16.2(f)-415.8(b)16.2(r)0(e)25.5(a)15(kt)26.5(h)16.2(r)0(o)26.6(u)0(g)26.6(h)-415.8(s)16.4(y)0(m)25.4(p)16.2(to)26.5(m)15(s)-415.6(a)15(n)0(d)]TJ
0 -1.1116 TD
[(re)25.5(l)16.1(i)0(e)25.3(f)-214.2(o)16.2(f)-214.2(sy)26.8(m)15(p)0(t)26.5(o)0(m)25.4(s)-214(i)16.1(n)-214.2(h)16.2(o)0(s)26.8(p)0(i)26.5(t)16.1(al)25.3(s)-214(a)15(nd)-203.8(n)16.2(u)16.2(r)0(s)26.8(i)0(n)26.5(g)-214.2(h)16.2(o)0(m)25.4(e)15(s,)-200.2(as)25.6(su)26.8(m)15(i)0(n)26.5(g)-214.2(a)]TJ
T*
[(n)16.2(u)0(l)26.5(l)-185.5(h)16.2(y)0(p)26.6(o)0(t)26.5(h)16.2(es)25.6(is)-169.2(\(H)]TJ
7.3823 0 0 6.5614 131.5842 115.2567 Tm
(0)Tj
9.843 0 0 9.843 135.1559 116.9008 Tm
[(\))16.2(,)-187.7(t)16.1(h)16.2(at)-176.3(i)16.1(s)16.4(,)-187.7(n)16.2(o)-185.4(d)16.2(if)26.5(f)16.2(e)0(r)25.5(e)0(n)25.4(c)15(es)-170.2(be)25.4(tw)25.6(e)15(e)0(n)-170.4(t)0(h)26.5(e)-186.6(g)16.2(r)0(o)26.6(u)16.2(ps)26.8(.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 62.022 94.9039 Tm
[(Patients)-334.4(and)-338.2(Methods)]TJ
/F5 1 Tf
9.843 0 0 9.843 72 78.463 Tm
[(The)-213(Methods)-211.3(section)-211.7(and)-211.8(the)-211.9(Results)-211.4(are)-212.9(reported)-212.8(based)-215(on)]TJ
-1.0137 -1.1116 TD
[(the)-286.8(Strengthening)-293.3(the)-286.8(Reporting)-288.8(of)-290.2(Observational)-289.6(Studies)-291(in)]TJ
T*
[(Epidemiology)-282.2(\(STROBE\))-284.6(criteria.)]TJ
7.3823 0 0 6.5614 198.3684 60.9449 Tm
(8)Tj
/F11 1 Tf
8.9663 0 0 8.9663 313.0582 725.7825 Tm
[(Study)-338.2(design)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 709.3416 Tm
[(We)-397.3(conducted)-399.4(a)-393.9(descriptive)-395.9(national)-397.4(registry)-395.9(data)-398.5(study)]TJ
-1.0137 -1.1116 TD
[(using)-379.8(the)-373.2(SRPC)-380.5(to)-370.9(characterize)-384.4(all)-373.3(registered)-383.1(patients)-380(who)]TJ
0 -1.1174 TD
[(died)-201.5(in)-198.2(COVID-19)-202.5(either)-199.2(in)-198.2(nursing)-197.7(homes)-203.5(or)-198(in)-198.2(hospitals)-201.1(and)]TJ
0 -1.1116 TD
[(we)-246.1(contrasted)-250.7(them)-243.1(to)-238.5(a)-244.2(year)-248.6(cohort)-244(before)-245(the)-240.7(pandemic)-249.8(\(all)]TJ
T*
[(death)-8(s)-277.4(registered)-285.2(in)-278.8(the)-281.1(SRPC)-282.6(in)-284.5(2019\).)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 313.0582 641.9337 Tm
(Population)Tj
/F3 1 Tf
1.1128 -1.6123 TD
[(Study)-243.4(population.)]TJ
/F5 1 Tf
9.843 0 0 9.843 407.6786 627.477 Tm
[(All)-194.5(registered)-198.8(patients)-195.6(who)-200(have)-196.8(died)]TJ
-9.6129 -1.1116 TD
[(from)-293.6(COVID)-9.1(-19)-291.3(as)-291.1(a)-296(cause)-296.8(of)-290.2(death)-295.9(\(diagnosis)-294.2(made)-296(by)-290.2(re-)]TJ
T*
[(spective)-478.9(physician\))-479.9(since)-474.3(March)-475.2(01,)-472.2(2020)-470.9(\(data)-480.2(retrieved)]TJ
T*
[(April)-248.5(24,)-247.5(2020\),)]TJ
/F6 1 Tf
6.687 0 TD
(n)Tj
/F7 1 Tf
.6624 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(511.)-242.9(An)-250.7(absolute)-247.4(majority)-247.7(\()]TJ
/F6 1 Tf
11.0298 0 TD
(n)Tj
/F7 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(490\))-246.3(died)]TJ
-20.4873 -1.1174 TD
[(either)-193.5(in)-186.6(nursing)-186.2(homes)-192(\()]TJ
/F6 1 Tf
9.7742 0 TD
(n)Tj
/F7 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.7142 0 TD
[(290\))-188.7(or)-186.5(in)-192.4(hospitals)-189.6(\()]TJ
/F6 1 Tf
8.0982 0 TD
(n)Tj
/F7 1 Tf
.6624 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(200\).)-186.4(For)]TJ
-20.637 -1.1116 TD
[(this)-327(reason,)-323.2(others)-318.7(\()]TJ
/F6 1 Tf
8.0578 0 TD
(n)Tj
/F7 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(21\))-320.1(were)-324.3(excluded)-323.5(to)-319.1(achieve)-323.5(as)-320(ho-)]TJ
-9.4459 -1.1116 TD
[(mogeneous)-261(groups)-259.8(as)-256.6(possible.)-255.2(Those)-261.1(excluded)-254.3(\()]TJ
/F6 1 Tf
19.5888 0 TD
(n)Tj
/F7 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(21\))-256.7(died)]TJ
-20.9769 -1.1174 TD
[(in)-486.1(specialized)-490.4(palliative)-493.2(care)-485.9(wards)-485.4(\()]TJ
/F6 1 Tf
15.8219 0 TD
(n)Tj
/F7 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
[(11\),)-484.8(in)-486.1(palliative)]TJ
-17.21 -1.1116 TD
[(home)-283.3(care)-284.3(\()]TJ
/F6 1 Tf
4.8036 0 TD
(n)Tj
/F7 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.7142 0 TD
[(2\))-284.4(or)-278.6(in)-278.8(their)-283.4(own)-280.6(homes)-284.2(\()]TJ
/F6 1 Tf
10.6439 0 TD
(n)Tj
/F7 1 Tf
.6624 0 TD
(=)Tj
/F5 1 Tf
.72 0 TD
(8\).)Tj
-17.1985 -1.1116 TD
-.0158 Tc
[(Of)-293.3(t)-15.8(h)10.7(e)-294.5(r).4(emai)-15.8(n)10.7(i).3(ng)-293.4(49)-15.8(0)-277.2(p)-15.8(a)9.6(tien)-15.8(t)10.7(s)-293.2(\(25)-15.8(3)-277.2(r)-15.8(e)9.7(s).6(id)-15.8(e)9.6(n).4(ts)-293.2(i)-15.8(n)-277.3(t)-15.8(h)10.7(e)-294.5(nurs)-15.8(i)10.9(n).4(g)]TJ
-1.0137 -1.1174 TD
[(h)-15.7(o)10.9(mes)-218.2(and)-212.6(2)-15.7(3)10.9(7)-212.6(pa)-15.7(t)9.6(i).3(en)-15.7(t)10.8(s)-212.4(in)-218.4(the)-219.5(hosp)-15.7(i)10.8(tal)-15.7(s)11(\),)-215(de)-15.7(a)8.6(t).4(h)-212.6(w)-15.7(a)8.9(s)-212.4(ex)-15.7(p)10.9(ecte)-15.7(d)-203.4(in)]TJ
0 -1.1116 TD
[(3)-15.8(9)10.8(0)-212.7(\(79)-15.8(.)14.2(6)-15.8(%)9.7(\))-212.7(case)-15.8(s)9.8(.)-209.3(F)-15.8(o)11(r)-212.7(thes)-15.8(e)-203.3(p).4(ers)-15.8(o)11(ns,)-215.1(t).3(he)-15.8(r)9.7(e)-213.9(are)-213.9(d).4(et)-15.8(a)9.5(i).2(le)-15.8(d)-197.7(d)-15.8(a)9.6(t).3(a)-213.9(o).4(n)]TJ
T*
[(s)-15.8(y)11(mpt)-15.8(o)10.7(ms)-281.7(and)-281.8(s).6(y)-15.8(m)9.6(ptom)-283.1(con)-15.8(t)10.7(rol)-282(du)-15.8(r)10.8(i).2(ng)-281.8(th)-15.8(e)-266.8(l)-15.8(a)9.5(s).6(t)-282(w)-.5(ee)-15.8(k)-266.8(o)-15.8(f)-271.4(l).3(ife)-15.8(.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 323.0361 472.4219 Tm
0 Tc
[(Reference)-254.7(population.)]TJ
/F5 1 Tf
9.843 0 0 9.843 425.9337 472.4219 Tm
[(All)-206(registered)-210.3(deaths)-210.5(in)-203.9(SRPC)-202(in)]TJ
-11.4676 -1.1116 TD
(2019,)Tj
/F6 1 Tf
2.5343 0 TD
(n)Tj
/F7 1 Tf
.6681 0 TD
(=)Tj
/F5 1 Tf
.7142 0 TD
(53,345.)Tj
/F11 1 Tf
8.9663 0 0 8.9663 313.0582 437.9526 Tm
[(Variables)-338.8(and)-331.9(data)-332.7(source)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 421.5117 Tm
-.0231 Tc
[(Th)4.6(e)-411.3(S)4.8(RP)4.8(C)-411.1(e)3.4(ncou)4.6(rages)-409.9(h)4.6(ealt)4.5(h)-410.1(c)3.4(ar)4.6(e)-411.3(t)4.5(o)-410.1(r)-1.1(epo)4.6(r)-1.1(t)-404.5(a)-2.3(l)4.5(l)-410.2(d)4.6(e)-2.3(ath)4.6(s)-1(,)-406.7(r)-1.1(e-)]TJ
-1.0137 -1.1174 TD
[(gard)4.5(less)-369.7(of)-369.8(car)4.5(e)-371(fo)4.5(rm,)-372.2(caus)4.7(e)-2.4(,)-372.2(o)4.5(r)-369.8(t)-1.4(r)4.5(a)-2.4(j)4.4(e)3.3(ct)4.4(or)4.5(y.)-372.2(F)4.7(o)-1.3(r)-369.8(a)3.3(ll)-370(d)4.5(e)-2.4(at)4.4(hs,)-366.5(d)-1.3(e-)]TJ
0 -1.1116 TD
-.0256 Tc
[(m)-4.9(o)2.1(gra)-4.8(p)2.1(hic)-356.2(d)2.1(ata,)-351.6(pla)-4.8(c).9(e)-356.2(o)2.1(f)-349.2(d)-3.7(ea)-4.8(th,)-351.6(c).9(a)-4.8(u)2.1(se)-350.4(of)-355(de)-4.8(ath,)-351.6(a)-4.8(n)2.1(d)-349.2(s)-3.5(o)-349.2(o)-3.7(n)-349.2(a)-4.8(re)]TJ
T*
-.0275 Tc
[(c)-6.7(o).2(l)-5.7(l).1(e)-6.7(c)-1(t)-5.7(e)-1(d)-5.6(.)-324.7(A)-323.2(s).4(p)-5.6(e)-1(c)-6.7(i).1()-5.4(c)-323.5(qu)-5.6(es)-5.4(ti)-5.7(on)-328.1(is)-322.1(p)-5.6(h).2(r)-5.5(a)-1(s)-5.4(e)-1(d)-328.1(i).1(n)-322.3(t)-5.7(he)-329.3(fo)-5.6(ll)-5.7(ow)-6.4(in)-5.6(g)-322.3(w)-.7(a)-6.7(y).2(:)]TJ
0 -1.1174 TD
-.0738 Tc
()Tj
/F6 1 Tf
.5702 0 TD
-.0238 Tc
[(Bas)4.1(e)-3(d)-238(o)3.9(n)-238(t)-2(h)3.9(e)-239.2(di)3.8(seas)4.1(e)-239.2(t)-2(r)4.1(a)-1.9(j)3.8(e)-3(cto)3.9(r)-1.7(y,)-240.3(was)-237.8(t)-2(h)3.9(e)-239.2(deat)3.8(h)-238(e)-3(xp)3.9(ected?)]TJ
/F5 1 Tf
21.5816 0 TD
-.0738 Tc
[()-288(F)-51.7(o)-46.1(r)]TJ
-22.1518 -1.1116 TD
-.0272 Tc
[(t)-5.4(h).5(o)-5.3(s)-5.1(e)-265.6(p)-5.3(at)-5.4(ie)-6.4(nt)-5.4(s)-264.2(w)-6.1(he)-6.4(re)-271.4(d)-5.3(eat)-5.4(h,)-272.5(ac)-6.4(co)-5.3(rd)-5.3(in)-5.3(g)-264.4(t)-5.4(o)-270.2(t).4(h)-5.3(e)-265.6(s)-5.1(t).4(a)-6.4(f).5(f)-5.2(,)-266.8(w)-6.1(a)-.7(s)-270(e)-.7(x)-5.3(p).5(e)-6.4(c)-.7(t)-5.4(e)-.7(d)]TJ
T*
0 Tc
(\()Tj
/F6 1 Tf
.311 0 TD
(n)Tj
/F7 1 Tf
.6393 0 TD
(=)Tj
/F5 1 Tf
.6969 0 TD
-.0227 Tc
[(3)5(9)-.8(0)5(\))-.7(,)-302.6(a)-1.9(n)-300.3(a)-1.9(n)5(o)-.8(n)5(y)-.8(mi)4.9(zed)-306(e)3.8(nd)5(-o)5(f-l)4.9(if)5(e)-307.2(q)5(uest)4.9(io)5(nn)5(ai)4.9(re)-301.4(\(ELQ\))-306(w)4.1(it)4.9(h)]TJ
-1.6473 -1.1174 TD
-.0273 Tc
[(m)-6.6(o).4(r)-5.3(e)-415.5(de)-6.5(ta)-6.5(il)-5.5(ed)-414.3(q)-5.4(u).4(e)-6.5(s).6(t)-5.5(i).3(o)-5.4(n).4(s)-419.9(i).3(s)-414.1(a)-6.5(va)-6.5(il)-5.5(ab)-5.4(le)-6.5(,)-410.9(w)-6.2(it)-5.5(h)-414.3(a)-415.5(t)-5.5(o).4(ta)-6.5(l)-414.4(o)-5.4(f)-414.3(2).4(4)-414.3(E)-6.6(OL)]TJ
0 -1.1116 TD
-.0221 Tc
[(qu)5.6(es)5.8(ti)5.5(on)5.6(s,)-290.5(as)-287.9(well)-288.3(as)-288(in)5.6(fo)5.6(rmat)5.5(io)5.6(n)-293.9(a)4.4(bo)5.6(ut)-288.3(th)5.6(e)-295.1(u)5.6(ni)5.5(t/)5.5(serv)5.6(ice)-295.1(a)4.4(nd)-288.1(th)5.6(e)]TJ
T*
-.0275 Tc
[(p)-5.6(e)-1(r)-5.5(s)-5.4(on)-5.6(\(s)-5.4(\))-443.3(w)-.7(ho)-443.3(c)-6.7(o).2(m)-6.8(p).2(l)-5.7(e)-1(t)-5.7(e)-1(d)-443.3(t).1(h)-5.6(e)-444.5(qu)-5.6(es)-5.4(ti)-5.7(on)-5.6(na)-6.7(ir)-5.5(e.)-439.9(T)-6.7(h).2(e)-444.5(E)-1(L)-6.8(Q)-444.2(is)-443.1(a)-6.7(n).2(-)]TJ
T*
-.0247 Tc
[(sw)-3.6(ered)-319.5(retrospec)-3.9(t)2.9(ive)-3.9(l)2.9(y)-319.5(o)-2.8(nline,)]TJ
11.8304 0 TD
-.0229 Tc
[(as)-323.3(s)5(o)-1(o)4.8(n)-317.7(as)-317.5(po)4.8(ss)5(ib)4.8(le)-318.9(aft)4.7(e)-2.1(r)-317.7(t)-1.1(h)4.8(e)-318.9(pa-)]TJ
-11.8304 -1.1174 TD
-.0218 Tc
[(ti)5.8(en)5.9(t)5.9(s)-328(d)5.9(eath)5.9(,)-324.7(b)5.9(y)-328.2(t)5.8(he)-323.6(n)5.9(u).1(r)5.9(s).3(e)-323.6(a)4.7(nd)5.9(/o)5.9(r)-328.1(t)5.8(he)-323.6(p)5.9(h).1(y)5.9(s).3(i)5.8(c)-1(i)5.8(a)-1(n)-322.4(r)5.9(es)6.1(po)5.9(ns)6.1(ib)5.9(le)-323.6(fo)5.9(r)]TJ
0 -1.1116 TD
-.0275 Tc
[(E)-6.8(O)-.7(L)-294.7(c)-1(a)-6.7(r).2(e)-6.7(.)-290.1(The)-294.7(E)-1(L)-6.8(Q)-288.7(r)-5.5(e)-1()-5.4(e)-1(c)-6.7(t).1(s)-293.4(s).4(y)-5.6(m)-1(pt)-5.7(om)-6.8(s)-287.6(d)-5.6(ur)-5.5(in)-5.6(g)-287.8(t)-5.7(he)-294.7(la)-6.7(st)-293.7(we)-6.7(ek)-293.5(of)]TJ
T*
-.0271 Tc
[(l)-5.3(i).5(f)-5.1(e)-.6(.)-220.6(O)-6(nl)-5.3(y)-218.3(d)-5.2(at)-5.3(a)-219.4(d)-5.2(ocu)-5.2(m)-.6(e)-6.3(n).6(t)-5.3(e)-.6(d)-224(i).5(n)-218.3(t)-5.3(he)-225.2(pa)-6.3(ti)-5.3(en)-5.2(t)-218.4(r)-5.1(eco)-5.2(rd)-5.2(s)-218.1(a)-6.3(re)-225.2(co)-5.2(ns)-5(id)-5.2(er)-5.1(ed)-5.2(.)]TJ
1.0137 -1.1174 TD
0 Tc
[(The)-391.6(questionnaire)-386.6(contains)-391.3(data,)-390.4(for)-383.4(example,)-390.4(about)-386.9(de-)]TJ
-1.0137 -1.1116 TD
[(mographics)-377.3(and)-373.1(the)-379(occurrence)-373.9(of)-376.5(breakthrough)-372.7(symptoms)]TJ
T*
[(\(regar)-8.8(dless)-380.8(of)-382.3(intensity\),)-384.5(and,)-376.5(when)-386.6(symptoms)-379.6(are)-385.7(present,)]TJ
0 -1.1174 TD
[(also)-212.8(the)-211.9(degree)-211.7(of)-209.5(symptom)-211.7(relief)-210.7(during)-208.3(the)-211.9(last)-213(week)-209.2(of)-209.5(life.)]TJ
0 -1.1116 TD
[(In)-186.5(this)-183(study,)-187.4(we)-182.8(focused)-188.4(on)-180.7(breathlessness,)-190(anxiety,)-186.5(delirium,)]TJ
T*
[(death)-313.2(rattles,)-313.1(and)-304(pain,)-308.6(as)-314.2(well)-306.2(as)-308.4(on)-307.5(medication)-315.6(used)-304.9(to)-307.6(re-)]TJ
0 -1.1174 TD
[(lieve)-388.2(symptoms.)-388.8(Prescriptions)-390.8(of)-382.3(parenteral)-390.2(nutrition/uids)]TJ
0 -1.1116 TD
[(were)-284(also)-282(analyzed.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 313.0582 167.811 Tm
[(Rating)-340.3(scales)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 151.37 Tm
[(For)-256.5(most)-253.2(items,)-253.3(the)-258(answers)-252.4(are)-259(provided)-252(in)-255.8(a)-255.7(YesNo)]TJ
-1.0137 -1.1174 TD
[(Do)-469.6(not)-464.2(know)-466.1(format,)-467.5(for)-464(example,)-471(for)-464(the)-465.4(occurrence)-471.8(of)]TJ
0 -1.1116 TD
[(symptoms.)-481(As)-475.2(regards)-482.1(relief)-481.4(of)-474.5(symptoms)-477.6(\(e.g.,)-481.3(relief)-475.7(of)]TJ
T*
[(breathlessness\),)-680.6(there)-670.3(are)-668(three)-670.3(alternatives:)-676(completely)]TJ
T*
[(relievedp)-10.1(artly)-277.6(relievednot)-288.9(relieved)-283.2(at)-280(all.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 313.0582 83.9622 Tm
[(Selection)-341.5(bias)]TJ
/F5 1 Tf
9.843 0 0 9.843 323.0361 67.5212 Tm
[(The)-339.7(SRPC)-340.2(is)-342(not)-337.5(mandatory,)-345.3(although)-338.5(its)-337.4(use)-344.1(is)-336.2(strongly)]TJ
-1.0137 -1.1116 TD
[(encou)-7.8(raged.)-281.9(In)-278.6(total,)]TJ
/F10 1 Tf
8.5992 0 TD
(*)Tj
/F5 1 Tf
.9964 0 TD
[(60%)-280.8(of)-284.4(all)-281.2(deaths)-285.3(are)-282.1(reported,)-285.4(from)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(2)Tj
46.8844 0 TD
[(STRANG)-337.5(ET)-338.7(AL.)]TJ
ET
endstream
endobj
34 0 obj
<>stream
h,J@ ⥃RQ#bK]z]..)gprgFaF=^ץ~??oeu~]ϊF0_]?ԟ#
>P0x@4E L`UyB,&r9X2T!~- *,Cu(Ц2d%S)`PE)KQWds8a`AG[vbO-n|>e(R8(1R4dW' }6
endstream
endobj
37 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(all)-229.4(services)-230.9(where)-233.3(death)-226.8(occur.)-230.1(In)-226.8(a)-226.9(year)-231.3(cohort,)-230.2(the)-223.5(coverage)]TJ
0 -1.1174 TD
[(is)-226.8(highest)-227.8(for)-227.9(specialized)-231.2(palliative)-228.3(care)-226.7(\()]TJ
/F7 1 Tf
16.3115 0 TD
(>)Tj
/F5 1 Tf
.5529 0 TD
[(90%\),)-227.7(followed)-224.2(by)]TJ
-16.8644 -1.1116 TD
[(nursing)-393.5(homes)-393.6(\(75%\),)-390.1(and)-390.4(hospitals)-391.2(\(50%\).)-390.1(Therefore,)-392.3(the)]TJ
T*
[(proportion)-293.4(of)-290.2(deaths)-291.1(in)-290.3(nursing)-295.6(homes)-289.9(versus)-295.3(hospitals)-293.3(does)]TJ
T*
[(not)-222.3(reect)-217.4(the)-217.7(absolute)-224.3(number)-216.3(of)-221(deaths)-216.2(\(as)-223.1(somewhat)-220.5(fewer)]TJ
0 -1.1174 TD
[(acute)-285.6(hospital)-280.9(departments)-287.6(report)-284.3(data\).)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 59.7543 646.5825 Tm
[(Study)-338.2(size)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 630.1416 Tm
[(The)-408.8(study)-414.4(covers)-411.9(all)-407.9(reported)-414.4(COVID-19-related)-416.6(deaths)]TJ
-1.0137 -1.1116 TD
[(\(total)-284.6(cohort\))-279.6(until)-282.4(April)-283.1(24,)-282.1(2020.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 59.7543 595.4455 Tm
[(Statistical)-336(methods,)-335.1(missing)-337.2(data)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 579.0046 Tm
[(Fishers)-251.4(\(two-tailed\))-253(exact)-251(test)-253.3(and)-246.4(\(two-tailed\))]TJ
/F6 1 Tf
19.1568 0 TD
(t)Tj
/F5 1 Tf
.5299 0 TD
[(test)-253.3(were)]TJ
-20.7004 -1.1116 TD
[(used.)-354.4(For)-348.7(most)-345.4(questions,)-354.2(the)-350.2(option)-346.7()50.8(Do)-349.7(not)-349(know)45.5()-346.6(i)0(s)-347.7(a)0(n)]TJ
T*
[(alternative.)-493(Statistics)-485.7(were)-491.4(calculated)-489.5(on)-480.3(denite)-488.2(answers)]TJ
0 -1.1174 TD
[(\(YesNo;)-501.2(or)-491.7(in)-497.7(the)-494.2(case)-497.3(of)-497.5(symptom)-493.9(relief:)-499.9(Complete)]TJ
0 -1.1116 TD
[(PartialNo)-286.2(relief)-89.8(\).)-281()50.8(Do)-280.6(not)-279.9(know)51.2()-283.3(answers)-287(were)-278.3(analyzed)]TJ
T*
[(separately)-286.4(\(Table)-286.7(3\).)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 59.7543 500.4849 Tm
(Ethics)Tj
/F5 1 Tf
9.843 0 0 9.843 69.7323 484.0439 Tm
-.0158 Tc
[(Acc)-15.8(o)9.6(rdi)-15.8(n)10.7(g)-166.6(to)-172.4(the)-173.6(S).5(wedi)-15.8(s)10.9(h)-166.6(l)-15.8(a)9.5(w,)-169(ethi)-15.8(c)9.5(a)-.8(l)-166.8(r)-15.8(e)9.7(v).4(iew)-173.3(i).3(s)-166.5(o)-15.8(n)10.8(l).3(y)-166.6(r)-15.8(e)9.7(qui)-15.8(r)10.7(e)-.8(d)]TJ
-1.0137 -1.1116 TD
-.0159 Tc
[(f)-15.9(o)10.7(r)-224.3(d)-15.9(a)9.5(t).2(a)-225.5(o)-15.9(n)-213.9(liv)-15.9(i)10.6(n).3(g)-224.3(p)-15.9(e)9.5(r).3(so)-15.9(n)10.7(s).5(.)-226.7(T)-.9(h)-15.9(e)9.5(refo)-15.9(r)10.7(e)-.9(,)-226.7(acc)-15.9(o)9.5(rdi)-15.9(n)10.6(g)-224.3(to)-230.1(the)-231.3(S).5(wed)-15.9(i)10.6(sh)]TJ
0 -1.1174 TD
[(l)-15.9(a)9.4(w)-328.9(\().3(2)-15.9(0)10.7(03:)-15.9(4)10.6(60\),)-330.4(f)-15.9(o)10.7(urt)-15.9(h)-317.7(p).3(ar)-15.9(a)9.6(grap)-15.9(h)-317.6(\(2)-15.9(0)10.7(03:6)-15.9(1)10.7(5\),)-330.4(s)-15.9(t)10.8(udi)-15.9(e)9.4(s)-327.8(en)-15.9(c)9.5(o).3(m-)]TJ
25.5097 26.725 TD
-.0157 Tc
[(pas)-15.7(s)11.3(ing)-160.8(d).5(ata)-162(o).5(n)-160.8(d).5(ece)-15.7(a)8.6(s).7(ed)-160.8(pers)-15.7(o)11.1(n).5(s)-160.6(w)-.4(it)-15.7(h)-144.7(e)-.7(nc)-15.7(r)9.8(ypt)-15.7(e)9.6(d)-155(i)-15.7(d)10.8(-nu)-15.7(m)9.7(b).5(ers)-160.6(\().5(as)]TJ
0 -1.1174 TD
[(in)-270.2(this)-270(cas)-15.7(e)9.9(\))-270.2(are)-271.4(not)-270.4(sub)-15.7(j)10.8(ect)-270.4(to)-270.2(the)-271.4(S).7(we)-15.7(d)9.7(i).4(sh)-270.2(law)-15.7(.)-257.3(The)-271.4(s).7(ame)-271.4(l).4(aw)]TJ
0 -1.1116 TD
[(als)-15.8(o)-236.7(wa)-15.8(i)9.5(v).4(es)-252.8(the)-254.2(r).4(eq)-15.8(u)10.8(i).3(re)-15.8(m)8.4(e)-.8(nt)-253.2(to)-253(obtai)-15.8(n)-237(i)-15.8(n)10.7(for)-15.8(m)9.6(a)-.8(l)-247.4(c)-15.8(o)9.6(n).4(se)-15.8(n)9.6(t).2(.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 681.2786 Tm
0 Tc
(Results)Tj
/F11 1 Tf
0 -1.8336 TD
[(COVID-19)-337.2(versus)-333.8(reference)-334.8(population)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 648.4534 Tm
.0131 Tc
[(In)-379.7(Ta)-6.4(ble)-380.8(1)-5.3(,)-376.2(d).5(e)-6.4(m)-.7(o)-5.3(g).5(r)-5.2(a)-.7(ph)-5.3(ic)-6.4(s)-379.5(a)-.7(n)-5.3(d)-373.9(s)-5.1(y).5(m)-6.5(p).5(t)-5.4(o).5(m)-380.9(d).5(at)-5.4(a)-380.8(a)-.7(r)-5.2(e)-375.1(c)-6.4(o).5(m-)]TJ
-1.0137 -1.1174 TD
[(pa)-6.3(re)-6.3(d)-333.5(b)-5.2(et)-5.3(wee)-6.3(n)-339.2(390)-339.2(e)-6.3(x).6(p)-5.2(ect)-5.3(ed)-339.2(de)-6.3(at)-5.3(hs)-339(in)-339.2(CO)-6(VI)-5.1(D-)-5.1(19)-339.2(an)-5.2(d)-339.2(a)-.6(ll)]TJ
0 -1.1116 TD
.0129 Tc
[(re)-6.6(gi)-5.6(st)-5.6(er)-5.4(ed)-345.3(d)-5.5(e)-.9(a)-6.6(t).2(h)-5.5(s)-345.1(du)-5.5(ri)-5.6(ng)-351.1(20)-5.5(19.)-347.6(C)-6.5(o).3(m)-6.7(p).3(ar)-5.4(ed)-351.1(wi)-5.6(th)-345.3(2)-5.5(0).3(1)-5.5(9)-345.3(po)-5.5(p-)]TJ
T*
.0148 Tc
[(ulation)-337.6(d)-3.6(ata)-4.7(,)-340(the)-338.8(d)-3.6(ec)-4.7(eased)-343.4(CO)]TJ
12.7001 0 TD
.0131 Tc
[(VID)-6.1(-).5(1)-5.3(9)-339.3(p)-5.3(a)-.7(t)-5.4(i).4(en)-5.3(ts)-344.9(we)-6.4(re)-346.3(ol)-5.4(der)]TJ
-12.7001 -1.1174 TD
0 Tc
(\()Tj
/F6 1 Tf
.5126 0 TD
(p)Tj
/F7 1 Tf
.6854 0 TD
(<)Tj
/F5 1 Tf
.7315 0 TD
.0132 Tc
[(0.0)-5.2(5).6(\))-5.1(,)-295.5(an)-5.2(d)-298.9(a)-294.3(l)-5.3(o).6(w)-6(e)-.6(r)-298.9(p).6(r)-5.1(opo)-5.2(rt)-5.3(io)-5.2(n)-293.2(w)-6(er)-5.1(e)-294.3(f)-5.1(ema)-6.3(le)-300.1(\()]TJ
/F6 1 Tf
18.5347 0 TD
0 Tc
(p)Tj
/F7 1 Tf
.6854 0 TD
(<)Tj
/F5 1 Tf
.7315 0 TD
.0126 Tc
[(0)-5.8(.)-2.3(05\))-5.7(.)]TJ
-21.8811 -1.1116 TD
.013 Tc
[(Ba)-6.5(sed)-374(o)-5.4(n)-368.2(t)-5.5(he)-375.2(di)-5.5(se)-6.5(as)-5.2(e)-369.4(t)-5.5(ra)-6.5(jec)-6.5(t).3(o)-5.4(r).4(y)-5.4(,)-370.6(de)-6.5(at)-5.5(h)-368.2(w)-6.2(as)-373.8(le)-6.5(ss)-373.8(o)-5.4(f).4(te)-6.5(n)-374(e)-.8(x-)]TJ
T*
.0128 Tc
[(pe)-6.7(cte)-6.7(d).2(,)-307.4(a)-1(c)-6.7(c)-1(or)-5.5(di)-5.7(ng)-305.1(t)-5.7(o)-305.1(th)-5.6(e)-306.2(s).4(t)-5.7(a)-1(f)-5.5(f).2(:)-305.2(8)-5.6(0%)-306.1(am)-6.8(ong)-310.8(the)-306.2(C)-6.6(OV)-6.4(ID)-6.4(-19)]TJ
0 -1.1174 TD
-.0159 Tc
[(deat)-15.9(h)10.6(s).5(,)-203.6(c)-15.9(o)9.5(m)-.9(pare)-15.9(d)-192(w)-.6(i)-15.9(t)10.4(h)-207.1(90%)-208.1(in)-201.3(t)-15.9(h)10.6(e)-202.5(2)-15.9(0)10.7(1).3(9)-207.1(popu)-15.9(l)10.6(a)-.9(tio)-15.9(n)-190.9(\()]TJ
/F6 1 Tf
20.1935 0 TD
0 Tc
(p)Tj
/F7 1 Tf
.6508 0 TD
(<)Tj
/F5 1 Tf
.7027 0 TD
-.0157 Tc
[(0.001)-15.7(\))10.9(.)]TJ
-21.5471 -1.1116 TD
-.0159 Tc
[(Sig)-15.9(n)10.7(ica)-15.9(n)9.5(t).2(ly)-316.5(mor)-15.9(e)-307.2(COVID)-15.9(-)9.9(19)-316.5(pa)-15.9(t)9.4(i).1(ent)-15.9(s)10.8(,)-313.1(4)-15.9(8)10.7(%)-317.6(vers)-15.9(u)10.9(s)-316.3(25%)-15.9(,)-303.7(e)-.9(x-)]TJ
T*
-.0158 Tc
[(peri)-15.8(e)9.5(n).4(ced)-189.7(a)-185.1(b).4(r)-15.8(e)9.7(akt)-15.8(h)10.7(roug)-15.8(h)-173.5(o).4(f)-189.7(brea)-15.8(t)9.5(hle)-15.8(s)9.8(sne)-15.8(s)9.8(s)-183.7(d)-15.8(u)10.8(r).4(in)-15.8(g)-173.5(t).2(he)-190.8(las)-15.8(t)-173.4(week)]TJ
0 -1.1174 TD
.0069 Tc
[(of)-293.7(l)-5.8(i)-.1(f)-5.7(e)-294.9(\()]TJ
/F6 1 Tf
3.3233 0 TD
0 Tc
(p)Tj
/F7 1 Tf
.6796 0 TD
(<)Tj
/F5 1 Tf
.7257 0 TD
.0112 Tc
[(0.0)4.3(01\))4.4(.)-291.7(B)3.3(reat)4.2(hless)4.5(n)-1.4(es)4.5(s)-289.2(w)-2.3(as)-289.2(completely)-283.6(rel)4.2(i)-1.5(eved)]TJ
-4.7287 -1.1116 TD
.0073 Tc
[(in)-385.5(3)-5.3(1).4(%)-386.5(a)-6.5(nd)-385.5(p)-5.3(a)-.7(r)-5.3(t)-5.4(ly)-385.4(o)-5.3(r)-385.4(co)-5.3(mp)-5.3(le)-6.5(te)-6.5(ly)-385.5(a)-6.5(l)-5.4(le)-6.5(vi)-5.4(at)-5.4(ed)-385.4(i)-5.5(n)-385.4(94)-5.3(%)-386.5(\().5(3)-5.3(1)-5.3(%)]TJ
/F7 1 Tf
T*
0 Tc
(+)Tj
/F5 1 Tf
.5587 0 TD
.0074 Tc
[(6)-5.2(3)-5.2(%)-.5(\))-224.1(o)-5.2(f)-224.1(t)-5.3(he)-225.2(C)-6.2(O)-.3(V)-6.1(I)-5.2(D-)-5.2(19)-229.8(pa)-6.4(ti)-5.3(en)-5.2(t)-5.3(s).7(,)-226.4(w)-6.1(hi)-5.3(ch)-224.1(w)-6.1(a)-6.4(s)-223.9(l).4(o)-5.2(w)-6.1(er)-224.1(t)-5.3(h).5(a)-6.4(n)-224.1(f)-5.2(o).5(r)]TJ
-.5587 -1.1116 TD
0 Tc
[(the)-344.4(ref)12.9(ere)11.7(nce)-345.5(pop)14(ula)12.7(ti)14.8(on)-353.5(\(Ta)17.4(ble)-350.2(1\).)-339.7(Thi)12.6(s)-358(m)0(e)12.7(ans)-349.9(th)15(at)-354.8(bre)12.8(at)13.8(h-)]TJ
0 -1.1174 TD
[(les)12.9(sne)13(ss)-416.5(rem)11.6(ain)12.7(ed)-418.1(unr)14(el)13.8(iev)12.7(ed)-418.1(in)-417(6%)-418(in)-422.8(the)-413.5(COV)17(ID-)13.2(19)-422.7(pa)13.9(-)]TJ
0 -1.1116 TD
[(tie)12.6(nts)14(,)-337.5(com)17.3(par)12.8(ed)-337.4(wi)14.1(th)-336.4(3%)-331.6(in)-336.4(the)-327.1(201)14(9)-335.2(ref)12.9(ere)11.7(nce)-328.2(pop)14(ula)12.7(tio)13.7(n.)]TJ
T*
[(The)-351.2(pop)14(ula)18.4(tio)13.7(ns)-359.1(al)13.8(so)-359.1(dif)13.9(fer)12.9(ed)-354.7(in)-353.7(rel)12.7(ief)-350.1(of)-353.5(anx)12.8(iet)12.6(y,)-350.1(del)12.7(iri)13.7(um,)]TJ
0 -1.1174 TD
[(dea)11.7(th)-267.3(rat)12.7(tle)12.6(s,)-269.3(and)-269.4(pa)13.9(in)-273(\(Ta)11.7(ble)-263.8(1\).)]TJ
ET
59.754 422.646 490.167 .28345 re
f
59.754 131.131 490.167 .28348 re
f
59.754 394.016 490.167 .22675 re
f
BT
/F9 1 Tf
9.845 0 0 9.845 73.3039 438.2928 Tm
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(1.)Tj
/F9 1 Tf
1.2496 0 TD
[(A)-335.8(Comparison)-336.2(between)-331.7(Patients)-337(Deceased)-330.7(in)-337.3(COVID-)]TJ
/F5 1 Tf
24.3126 0 TD
(19)Tj
/F9 1 Tf
1.3302 0 TD
[(and)-337.8(All)-332(Registered)-333(Expected)-338.1(Deaths)]TJ
-26.5411 -1.0135 TD
(during)Tj
/F5 1 Tf
3.4436 0 TD
(2019)Tj
/F9 1 Tf
7.3837 0 0 6.5625 159.9306 432.7369 Tm
(a)Tj
9.845 0 0 9.845 167.3007 428.3148 Tm
(\()Tj
/F12 1 Tf
.334 0 TD
(n)Tj
/F7 1 Tf
.7774 0 TD
(=)Tj
/F5 1 Tf
.7198 0 TD
(390)Tj
/F9 1 Tf
1.8312 0 TD
[(Out)-339(of)]TJ
/F5 1 Tf
3.5012 0 TD
(490)Tj
/F9 1 Tf
1.8312 0 TD
(COVID-)Tj
/F5 1 Tf
3.4897 0 TD
(19)Tj
/F9 1 Tf
1.336 0 TD
[(Deaths)-335.8(and)]TJ
/F5 1 Tf
5.6549 0 TD
(46,698)Tj
/F9 1 Tf
3.0866 0 TD
(of)Tj
/F5 1 Tf
1.3302 0 TD
(53,345)Tj
/F9 1 Tf
3.0808 0 TD
[(Deaths)-335.8(in)]TJ
/F5 1 Tf
4.8372 0 TD
(2019)Tj
/F9 1 Tf
1.9982 0 TD
(\))Tj
/F6 1 Tf
-44.7324 -2.8505 TD
(Characteristics)Tj
19.6021 1.0135 TD
[(COVID-19)-334.2(patients)-337.7(in)-330.4(hospitals)-337.3(and)]TJ
.8983 -1.0135 TD
[(nursing)-335(homes,)-338.4(expected)-336.4(deaths)]TJ
16.193 1.0135 TD
[(All)-332.7(registered)-341.5(expected)]TJ
1.6815 -1.0135 TD
[(deaths)-335.3(in)-336.2(2019)]TJ
/F5 1 Tf
9.5765 0 TD
(p)Tj
7.3837 0 0 6.5625 536.7683 404.6172 Tm
(b)Tj
9.845 0 0 9.845 59.7543 381.5432 Tm
[(Patients)-338.7(\(expected/all)-336.1(deaths\),)]TJ
/F6 1 Tf
12.5248 0 TD
(N)Tj
/F5 1 Tf
12.83 0 TD
[(390/490)-9883(46,698/53,345)]TJ
-25.3549 -1.0077 TD
[(Age,)-336.6(mean)-335.7(\(range\))-17233.1(84.7)-334.6(\(47104\))-10160.2(82.0)-334.6(\(0111\))]TJ
/F7 1 Tf
46.9897 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-47.5425 -1.0135 TD
[(Female)-338.9(sex)-332.2(\(%\))-16899.5(189/390)-335.3(\(48\))-8129.3(25,437/46,698)-334.5(\(54\))]TJ
/F7 1 Tf
46.9897 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.05)Tj
-47.5425 -1.0135 TD
[(Breathlessness)-341.7(\(%\))]TJ
7.3837 0 0 6.5625 135.8929 356.0314 Tm
(c,d)Tj
9.845 0 0 9.845 289.7007 351.666 Tm
[(173/362)-335.3(\(48\))-8129.3(11,271/44,419)-334.5(\(25\))]TJ
/F7 1 Tf
23.6331 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-46.5406 -1.0135 TD
[(Complete)-335.2(relief)-16495.4(53/173)-334.3(\(31\))-8877.9(4715/11,271)-335.9(\(42\))]TJ
/F7 1 Tf
45.9877 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.01)Tj
-46.5406 -1.0077 TD
(Partial)Tj
/F7 1 Tf
2.6259 0 TD
(+)Tj
/F5 1 Tf
.5528 0 TD
[(complete)-335.4(relief)]TJ
7.3837 0 0 6.5625 161.4047 336.1322 Tm
(e)Tj
9.845 0 0 9.845 289.7007 331.7668 Tm
[(162/173)-335.3(\(94\))-8129.3(10,923/11,271)-334.5(\(97\))]TJ
/F7 1 Tf
23.6331 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.02)Tj
-47.5425 -1.3187 TD
[(Anxiety)-337.5(\(%\))]TJ
7.3837 0 0 6.5625 109.5874 323.1495 Tm
[(c,)-9.4(d)]TJ
9.845 0 0 9.845 289.7007 318.7842 Tm
[(197/348)-335.3(\(57\))-8129.3(24,356/42,539)-334.5(\(57\))-2439.8(NS)]TJ
-22.3547 -1.0135 TD
[(Complete)-335.2(relief)-15994.4(131/197)-335.3(\(66\))-8129.3(17,858/24,356)-334.5(\(73\))]TJ
/F7 1 Tf
45.9877 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.05)Tj
-46.5406 -1.0077 TD
(Partial)Tj
/F7 1 Tf
2.6259 0 TD
(+)Tj
/F5 1 Tf
.5528 0 TD
[(complete)-335.4(relief)]TJ
7.3837 0 0 6.5625 161.4047 303.2503 Tm
(e)Tj
9.845 0 0 9.845 289.7007 298.885 Tm
[(194/197)-335.3(\(98\))-8129.3(24,215/24,356)-334.5(\(99\))-2439.8(NS)]TJ
-23.3567 -1.3187 TD
[(Delirium)-339.8(\(%\))]TJ
7.3837 0 0 6.5625 113.4992 290.2676 Tm
(c,d)Tj
9.845 0 0 9.845 294.633 285.9023 Tm
[(77/329)-334.3(\(23\))-8129.3(10,817/41,120)-334.5(\(26\))-2439.8(NS)]TJ
-22.8557 -1.0077 TD
[(Complete)-335.2(relief)-16996.3(13/77)-333.4(\(17\))-8877.9(2952/10,817)-335.9(\(27\))]TJ
/F7 1 Tf
45.9877 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.05)Tj
-46.5406 -1.0135 TD
(Partial)Tj
/F7 1 Tf
2.6259 0 TD
(+)Tj
/F5 1 Tf
.5528 0 TD
[(complete)-335.4(relief)]TJ
7.3837 0 0 6.5625 161.4047 270.3684 Tm
(e)Tj
9.845 0 0 9.845 299.5653 266.0031 Tm
[(60/77)-333.4(\(78\))-8877.9(8565/10,817)-335.9(\(79\))-2439.8(NS)]TJ
-24.3586 -1.3187 TD
[(Death)-336.5(rattles)-337.9(\(%\))]TJ
7.3837 0 0 6.5625 128.9196 257.4424 Tm
(c,d)Tj
9.845 0 0 9.845 289.7007 253.0204 Tm
[(178/368)-335.3(\(48\))-8129.3(23,466/45,737)-334.5(\(51\))-2439.8(NS)]TJ
-22.3547 -1.0077 TD
[(Complete)-335.2(relief)-16495.4(72/178)-334.3(\(40\))-8129.3(11,335/23,466)-334.5(\(48\))]TJ
/F7 1 Tf
45.9877 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.05)Tj
-46.5406 -1.0135 TD
(Partial)Tj
/F7 1 Tf
2.6259 0 TD
(+)Tj
/F5 1 Tf
.5528 0 TD
[(complete)-335.4(relief)]TJ
7.3837 0 0 6.5625 161.4047 237.4866 Tm
(e)Tj
9.845 0 0 9.845 289.7007 233.1212 Tm
[(171/178)-335.3(\(96\))-8129.3(22,401/23,466)-334.5(\(95\))-2439.8(NS)]TJ
-23.3567 -1.3187 TD
[(Pain)-339.1(\(%\))]TJ
7.3837 0 0 6.5625 95.3575 224.5606 Tm
(c,d)Tj
9.845 0 0 9.845 289.7007 220.1385 Tm
[(210/368)-335.3(\(57\))-8129.3(33,500/45,157)-334.5(\(74\))]TJ
/F7 1 Tf
23.6331 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-46.5406 -1.0077 TD
[(Complete)-335.2(relief)-15994.4(162/210)-335.3(\(77\))-8129.3(26,827/33,500)-334.5(\(80\))-2439.8(NS)]TJ
0 -1.0135 TD
(Partial)Tj
/F7 1 Tf
2.6259 0 TD
(+)Tj
/F5 1 Tf
.5528 0 TD
[(complete)-335.4(relief)]TJ
7.3837 0 0 6.5625 161.4047 204.6047 Tm
(e)Tj
9.845 0 0 9.845 289.7007 200.2393 Tm
[(209/210)-335.3(\(100\))-8130.3(33409/33500)-333.5(\(100\))-1939.8(NS)]TJ
-23.3567 -1.3129 TD
[(p.r.n.)-335.6(prescriptions)-337.9(strong)-334.2(opioid)-334.5(\(%\))]TJ
7.3837 0 0 6.5625 208.97 191.6787 Tm
(c)Tj
9.845 0 0 9.845 289.7007 187.3133 Tm
[(376/390)-335.3(\(96\))-8129.3(44,474/46,557)-334.5(\(96\))-2439.8(NS)]TJ
-23.3567 -1.0135 TD
[(p.r.n.)-335.6(prescriptions)-337.9(tranquilizer)-338.6(\(%\))]TJ
7.3837 0 0 6.5625 201.4866 181.7007 Tm
(c)Tj
9.845 0 0 9.845 289.7007 177.3354 Tm
[(376/390)-335.3(\(96\))-8129.3(43,963/46,492)-334.5(\(95\))-2439.8(NS)]TJ
-23.3567 -1.0135 TD
[(p.r.n.)-335.6(prescriptions)-337.9(antiemetic)-338.9(\(%\))]TJ
7.3837 0 0 6.5625 197.1779 171.7228 Tm
(c)Tj
9.845 0 0 9.845 289.7007 167.3574 Tm
[(357/390)-335.3(\(92\))-9085.2(41,334/4,630,889\))-1901.4(NS)]TJ
-23.3567 -1.0135 TD
[(p.r.n.)-335.6(prescriptions)-337.9(antimuscarinic)-337(\(%\))]TJ
7.3837 0 0 6.5625 214.1291 161.8015 Tm
(c)Tj
9.845 0 0 9.845 289.7007 157.3795 Tm
[(370/390)-335.3(\(95\))-8129.3(43,440/46,477)-334.5(\(93\))-2439.8(NS)]TJ
-23.3567 -1.0077 TD
[(Parenteral/enteral)-262.8(uids,)-255.8(nutrition)-251.5(during)-253.7(the)]TJ
.9962 -1.0135 TD
[(last)-333.6(day)-332.4(of)-336(life)-333.7(\(%\))]TJ
7.3837 0 0 6.5625 146.8346 141.8456 Tm
(c)Tj
9.845 0 0 9.845 294.633 147.4582 Tm
[(57/379)-334.3(\(15\))-8877.9(5100/46,404)-335.9(\(11\))]TJ
/F7 1 Tf
23.1321 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.05)Tj
6.5633 0 0 5.8334 67.748 123.2504 Tm
(a)Tj
8.7511 0 0 8.7511 70.696 119.3385 Tm
-.0544 Tc
()Tj
/F6 1 Tf
.609 0 TD
0 Tc
[(I)-334.3(d)0(o)-328.1(not)-338.6(know)]TJ
/F5 1 Tf
5.7269 0 TD
[()60.9()-334.3(was)-335.2(an)-335.7(option)-327.4(for)-337(most)-333.4(questions.)-331(Therefore,)-337.4(numbers)-330.9(may)-332.1(not)-332.1(sum)-335.8(to)-333.3(group)-329.6(totals.)]TJ
6.5633 0 0 5.8334 67.748 114.2928 Tm
(b)Tj
/F6 1 Tf
8.7511 0 0 8.7511 71.0362 110.3811 Tm
(p)Tj
/F5 1 Tf
.9523 0 TD
[(Values)-454.7(indicate)-456.9(differences)-451.1(between)-456.3(COVID-19)-450.5(patients)-454.1(and)-457.6(all)-448.6(registered)-457.8(deaths)-452.4(in)-449.9(2019.)]TJ
/F6 1 Tf
38.8054 0 TD
(p)Tj
/F7 1 Tf
.6673 0 TD
(<)Tj
/F5 1 Tf
.7191 0 TD
[(0.05)-452.6(was)-451.8(considered)-454(statistically)]TJ
-42.4333 -1.0236 TD
(signicant.)Tj
6.5633 0 0 5.8334 67.748 96.3212 Tm
(c)Tj
8.7511 0 0 8.7511 70.696 92.4661 Tm
[(Data)-335.6(based)-331.8(on)-334.5(those)-329.4(whose)-332.9(death)-338.6(was)-335.2(expected,)-333.6(that)-330.9(is,)-334.3(390)-333.4(versus)-332.9(46,698)-333.7(patients.)]TJ
6.5633 0 0 5.8334 67.748 87.3637 Tm
(d)Tj
8.7511 0 0 8.7511 71.0362 83.4519 Tm
[(The)-324.2(question)-324.6(posed)-324.1(was)-328.7()54.4(Did)-325.3(the)-326.8(person)-321.5(display)-325.8(breakthrough)-327.6(of)-320.1(any)-328.1(of)-326.6(the)-326.8(following)-323.4(symptoms)-324.7(at)-321.5(any)-328.1(time)-328.4(during)-320.7(the)-326.8(last)-322.8(week)-330.3(of)]TJ
-1.2892 -1.0236 TD
[(life?)55.4()-334.3(Alternatives)-333.5(for)-337(answers)-335.2(on)-328.1(symptom)-334(relief)-333.3(were)-335.4()54.4(Completely,)54.5()-327.8()54.4(Partially,)56.2()-334.3(and)-334.6()60.9(Not)-338.3(at)-328(all.)56.6()]TJ
6.5633 0 0 5.8334 67.748 69.4488 Tm
(e)Tj
8.7511 0 0 8.7511 70.696 65.537 Tm
[(For)-331.8(each)-335.7(symptom,)-330.1()54.4(Complete)-331.3(relief)51.5()-327.8(i)0(s)-338.1(a)-330.4(subset)-333.1(of)-333.1()54.4(Partial)-336(and)-328.1(complete)-339.1(relief.)55.3()]TJ
-.3369 -1.0236 TD
[(p.r.n.,)-329.6(as)-334.1(needed.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(SYMPTOM)-340.8(RELIEF)-335.9(IN)-328.8(ELDERLY)-339.4(DYING)-338.9(COVID-19)-330.9(PATIENTS)-25116.1(3)]TJ
ET
endstream
endobj
43 0 obj
<>stream
/GS1 gs
BT
/F11 1 Tf
8.9663 0 0 8.9663 62.022 725.7825 Tm
0 0 0 rg
0 Tc
0 Tw
[(COVID-19)-337.2(in)-331.6(nursing)-334.7(homes)-336.5(versus)-333.8(hospitals)]TJ
/F5 1 Tf
9.843 0 0 9.843 72 709.3416 Tm
[(Nursing)-233.1(homes)-232.3(and)-229.1(hospitals)-229.9(were)-238(contrasted)-233.4(in)-227(a)-232.6(separate)]TJ
-1.0137 -1.1116 TD
[(analysis.)-337(Compared)-341.7(with)-333.8(patients)-339.6(dying)-333.9(at)-337.6(hospitals,)-337.1(deaths)]TJ
0 -1.1174 TD
[(in)-198.2(nursing)-197.7(homes)-203.5(were)-197.6(more)-202.6(often)-196.8(expected,)-201.3(90%)-200.2(versus)-197.4(75%)]TJ
0 -1.1116 TD
(\()Tj
/F6 1 Tf
.5011 0 TD
(p)Tj
/F7 1 Tf
.6681 0 TD
(<)Tj
/F5 1 Tf
.7142 0 TD
[(0.001\).)-225.5(Those)-220.8(dying)-218.7(in)-221.2(nursing)-220.7(homes)-220.8(were)-226.4(signicantly)]TJ
-1.8834 -1.1116 TD
[(older)-323.5(and)-321.2(more)-323.5(often)-323.5(female,)-320.1(see)-322.2(Table)-325.9(2.)-321.3(The)-322.4(greatest)-323.4(dif-)]TJ
0 -1.1174 TD
[(ference)-260(betwe)-8.8(en)-256.8(the)-258(two)-257.7(groups)-259.8(was)-258.6(seen)-260(for)-256.7(breathlessness.)]TJ
0 -1.1116 TD
[(Compared)-289.8(with)-287.8(hospitals,)-291(breathlessness)-290.2(occurred)-288.7(less)-287.5(often)]TJ
T*
[(in)-336.4(nursing)-341.7(homes,)-339.4(35%)-332.7(versus)-341.4(73%)-338.4(\()]TJ
/F6 1 Tf
15.3899 0 TD
(p)Tj
/F7 1 Tf
.6624 0 TD
(<)Tj
/F5 1 Tf
.72 0 TD
[(0.0001\),)-341.7(and)-332.8(com-)]TJ
-16.7723 -1.1116 TD
[(plete)-313.4(relief)-308.6(was)-310.4(more)-306.3(often)-312(possible)-309.4(in)-307.6(nursing)-307.1(homes,)-310.6(42%)]TJ
0 -1.1174 TD
[(versus)-214.7(20%)-217.5(\()]TJ
/F6 1 Tf
5.3104 0 TD
(p)Tj
/F7 1 Tf
.6681 0 TD
(<)Tj
/F5 1 Tf
.72 0 TD
[(0.01\).)-212.8(However,)-216.8(partial)]TJ
/F7 1 Tf
9.2501 0 TD
(+)Tj
/F5 1 Tf
.5529 0 TD
[(complete)-215.4(relief)-216.5(was)]TJ
-16.5016 -1.1116 TD
[(possible)-430.3(in)-428.5(similar)-430.7(proportions,)-430.3(95%)-430.6(and)-430.7(92%,)-428.3(in)-428.5(nursing)]TJ
T*
[(homes)-284.2(and)-280.9(hospitals,)-279.5(respectively)-288.7(\(ns\).)]TJ
1.0137 -1.1174 TD
[(There)-556.2(were)-560.5(also)-558.4(differences)-563.8(as)-556.1(regards)-556.9(delirium)-558.7(\(less)]TJ
-1.0137 -1.1116 TD
[(common)-344.3(in)-347.9(nursing)-341.7(homes\),)-346.3(and)-344.3(complete)-347.9(relief)-348.9(of)-342(anxiety)]TJ
T*
[(and)-390.4(pain)-397.4(\(more)-388(common)-396.1(in)-388.2(nursing)-393.5(homes\),)-392.4(Table)-395.1(2.)-390.4(Par-)]TJ
0 -1.1174 TD
[(enteral)-449.2(uids)-448.8(to)-445.8(the)-442.3(dying)-449.1(were)-445.3(more)-450.3(often)-444.5(prescribed)-452.1(in)]TJ
0 -1.1116 TD
[(hospitals)-281.8(\()]TJ
/F6 1 Tf
4.3428 0 TD
(p)Tj
/F7 1 Tf
.6624 0 TD
(<)Tj
/F5 1 Tf
.72 0 TD
[(0.001\).)-277.3(For)-279.6(the)-275.3(alleviation)-281.2(of)-278.6(symptoms,)-279.4(there)]TJ
-5.7251 -1.1116 TD
[(were)-238(adequ)-7.8(ate)-236.1(p.r.n.)-238.2(prescriptions)-241.2(in)]TJ
/F7 1 Tf
14.7506 0 TD
(>)Tj
/F5 1 Tf
.5529 0 TD
[(87%)-234.8(of)-238.3(the)-240.7(cases,)-236.7(with)]TJ
-15.3035 -1.1174 TD
[(no)-284.4(differences)-287.3(between)-288.7(nursing)-289.8(homes)-284.2(and)-280.9(hospitals,)-291(except)]TJ
0 -1.1116 TD
[(for)-561.9(antiemetics)-571.3(that)-564.5(were)-560.5(more)-565.5(frequently)-566.5(prescribed)-567.3(in)]TJ
T*
[(nursing)-284.1(homes)-278.4(\()]TJ
/F6 1 Tf
6.6755 0 TD
(p)Tj
/F7 1 Tf
.6681 0 TD
(<)Tj
/F5 1 Tf
.72 0 TD
[(0.05\))-278.5(\(Table)-280.9(2\).)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 62.022 462.614 Tm
[()53.4()0(I)-329.5(d)0(o)-340.1(not)-329.6(know)53.6(answers)]TJ
/F5 1 Tf
9.843 0 0 9.843 72 446.1731 Tm
[()50.8()0(I)-330.4(d)0(o)-330.5(not)-331.7(know)51.2(answers)-336.3(were)-335.9(analyzed)-336.1(separately.)-335.9(In)]TJ
-1.0137 -1.1174 TD
[(every)-238.2(comparison)-239.1(except)-234.9(for)-239.4(parenteral)-240.5(uids,)-233.3(the)-235(proportion)]TJ
0 -1.1116 TD
[(was)-281.6(signicantly)-286.4(higher)-278.6(in)-284.5(hospitals,)-279.5(Table)-285.6(3.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 313.0582 725.7825 Tm
(Discussion)Tj
/F5 1 Tf
9.843 0 0 9.843 323.0361 709.3416 Tm
[(Many)-202.3(of)-198(the)-194.7(reports,)-202.2(so)-197.8(far,)-197.9(are)-201.4(on)-198(COVID-19)-202.5(patients)-201.4(with)]TJ
-1.0137 -1.1116 TD
[(ARDS,)-194.8(struggling)-189.7(for)-187.5(their)-185.4(lives)-191(in)-186.6(respirators)-192.8(at)-187.8(ICUs.)-188.1(To)-187.7(our)]TJ
0 -1.1174 TD
[(knowledge,)-431.4(this)-419.2(is)-428.4(the)-419.3(rst)-424.6(systematic)-430.4(report)-422.5(on)-422.7(symptom)]TJ
0 -1.1116 TD
[(prevalence)-402.8(and)-401.9(symptom)-396(relief)-400.8(focusing)-401.5(on)-393.9(dying)-397.3(patients)]TJ
T*
[(outside)-285.4(ICUs.)]TJ
1.0137 -1.1174 TD
[(Compared)-445.4(with)-437.5(the)-442.3(reference)-441.8(data,)-442.3(patients)-443.3(dying)-437.6(from)]TJ
-1.0137 -1.1116 TD
[(COV)11.2(ID-)13.2(19)-399.6(wer)12(e)-399.7(eld)12.7(erl)12.7(y,)-396.2(suf)14.2(fer)12.9(ed)-395(mor)12.8(e)-405.4(oft)13.9(en)-395(fro)14(m)-399.7(bre)12.8(ath)12.7(-)]TJ
T*
[(les)12.9(sne)13(ss)-502.9(tha)18.4(t)-508.1(w)0(a)13(s)-507.8(dif)13.9(c)14.1(ult)-498.9(to)-497.7(co)13.9(mpl)12.6(ete)11.5(ly)-497.7(rel)12.7(iev)12.7(e,)-495.3(whe)11.9(rea)11.7(s)]TJ
T*
[(bre)12.9(akt)12.7(hro)14(ugh)-302.8(pa)13.9(in)-307.6(was)-298.9(les)12.9(s)-311.9(com)17.3(mon)12.7(.)-308.7(Als)13.2(o,)-304(in)-307.6(ge)13.9(ner)12.9(al,)-300.7(the)12.7(re)]TJ
0 -1.1174 TD
[(wer)12(e)-313.3(mor)12.8(e)-313.3(bre)18.6(akt)12.7(hro)14(ugh)-302.8(sym)12.9(pto)13.9(ms)-302.7(in)-307.6(the)-304.1(COV)11.2(ID-)13.2(19)-301.7(pop)14(u-)]TJ
0 -1.1116 TD
[(lat)12.6(ion)-268.4(and)-263.6(the)-269.5(cha)11.7(nc)13.9(e)-278.7(t)0(o)-267.3(sym)12.9(pto)13.9(m)-278.8(rel)12.7(ie)13.8(f)-277.5(was)-270.1(lo)15(wer)12(.)]TJ
1.0137 -1.1116 TD
[(However,)-337.7(the)-332.9(data)-335.2(from)-333.9(nursing)-335.9(homes)-336(with)-333.8(surprisingly)]TJ
-1.0137 -1.1174 TD
[(low)-292.3(prevalence)-293.4(of)-290.2(symptomssymptoms)-289.2(that)-293.8(in)-284.5(most)-293.6(cases)]TJ
0 -1.1116 TD
[(were)-335.9(possible)-332.4(to)-330.6(alleviate)-331.9(completely)-332.9(or)-330.5(at)-331.8(least)-330.4(partially)]TJ
T*
[(are)-374.2(in)-365.2(contrast)-368.3(with)-368.4(anecdotal)-371.9(reports)-371.6(on)-365.1(agonized)-369.5(patients)]TJ
0 -1.1174 TD
[(dy)20.8(in)20.7(g)-421.6(i)0(n)-417(I)0(C)25.6(U)0(s)20.2(.)-423.9(Th)19.6(e)-422.7(c)0(o)19.7(r)0(e)-412.3(s)0(y)21(m)0(p)19.6(t)0(o)20.7(m)15(,)-423.9(b)0(r)20.9(e)0(a)18.5(t)0(h)20.7(l)0(e)25.3(s)0(s)21.2(n)0(e)19.7(s)0(s)21.2(,)-423.9(wa)18.8(s)-421.4(r)0(e)19.7(-)]TJ
0 -1.1116 TD
[(po)20.8(rt)20.7(ed)-314.4(in)-313.3(35)20.8(%)-318.9(i)0(n)-313.3(n)0(u)20.8(r)0(s)21.1(i)0(n)20.7(g)-317.9(ho)20.8(me)18.4(s,)-309.6(in)-313.4(gr)20.9(ea)18.5(t)-323.8(c)15(on)20.8(tr)20.8(as)19.9(t)-323.8(t)0(o)-313.4(7)0(3)20.8(%)-318.9(at)]TJ
T*
[(ho)20.8(sp)21(it)20.6(al)19.5(s)-352.2(a)0(n)19.7(d)-358.2(al)19.6(m)15(o)0(s)21(t)-358.3(in)-342.1(li)20.6(ne)-343.2(wi)19.8(th)-347.9()16.3(g)0(u)20.8(r)0(e)19.7(s)-358(\(2)20.9(5%)25.5(\))-358.2(f)0(o)20.9(r)-352.4(th)20.7(e)-353.6(t)0(o)20.7(t)0(a)19.5(l)]TJ
0 -1.1174 TD
[(co)19.7(ho)20.8(rt)-186.6(of)-186.5(al)19.5(l)-197.1(p)0(a)19.7(t)0(i)20.6(e)15(nt)20.7(s)-196.7(d)0(y)20.8(i)0(n)20.7(g)-196.9(in)-186.6(20)20.8(19)20.8(.)-193.5(M)0(e)18.8(a)0(n)19.7(w)0(h)20(i)0(l)26.3(e)0(,)-190(t)0(h)20.7(e)-198.1(po)20.8(ss)21.2(ib)26.5(il)20.6(it)20.6(y)]TJ
0 -1.1116 TD
[(to)-451.6(co)19.7(mp)19.6(le)19.6(t)16(e)-463(re)19.7(li)20.6(ef)-452.6(of)-445.7(br)20.9(ea)18.5(th)20.7(le)19.5(ss)21.2(ne)19.7(ss)-451.1(w)15.3(a)0(s)-452.4(h)0(i)20.7(g)0(h)20.8(e)0(r)-452.6(i)0(n)-445.8(n)0(u)20.8(r)0(s)21.1(i)0(n)20.7(g)]TJ
T*
[(ho)20.8(me)18.4(s.)-257.8(Th)19.6(us)21(,)-262.6(o)0(u)20.8(r)-271.8(nu)26.6(ll)-261.6(hy)20.8(p)16.2(o)0(t)20.7(h)0(e)19.7(s)0(i)20.9(s)-265.9(\(c)19.7(om)19.6(pa)19.7(ra)19.7(bl)20.7(e)-267.2(s)0(y)21(m)15(pt)20.7(om)19.6(s)-265.9(a)0(n)19.7(d)]TJ
T*
[(sy)21(mp)19.6(to)20.7(m)-347.9(r)0(e)19.7(l)0(i)26.3(e)0(f)-337.4(i)0(n)-336.4(d)0(y)20.8(i)0(n)20.7(g)-346.7(pe)19.7(rs)21.1(on)26.6(s)-346.5(r)0(e)19.7(g)0(a)19.7(r)0(d)20.9(l)0(e)19.6(s)0(s)-335.9(o)0(f)-336.2(s)0(e)19.9(r)0(v)20.9(i)0(c)25.3(e)0(s)19.9(\))-346.6(wa)18.8(s)]TJ
0 -1.1174 TD
[(re)19.7(je)19.6(ct)19.5(ed)19.7(.)]TJ
1.0137 -1.1116 TD
[(A)-405.1(possible)-401.5(explanation)-401.9(is)-405.3(that)-397.5(these)-405.2(frail)-404.3(elderly)-401.9(people)]TJ
-1.0137 -1.1116 TD
[(die)-235(early)-232.6(in)-227(the)-235(course,)-231(in)-232.7(most)-230.2(cases)-233.2(before)-233.5(ARDS)-231.7(develops.)]TJ
0 -1.1174 TD
[(This)-270.5(is)-272.8(strongly)-268(supported)-270.2(by)-267.1(local)-273(data)-271.8(from)-270.5(nursing)-266.8(homes)]TJ
0 -1.1116 TD
[(in)-238.5(the)-240.7(Stockholm)-242.8(region,)-241.7(were)-238(the)-240.7(median)-240.7(duration)-240.6(from)-241.7(rst)]TJ
ET
62.022 384.831 490.167 .22678 re
f
62.022 113.216 490.167 .22675 re
f
62.022 366.123 490.167 .22675 re
f
BT
/F9 1 Tf
9.845 0 0 9.845 120.3023 400.4219 Tm
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(2.)Tj
/F9 1 Tf
1.2496 0 TD
[(A)-335.8(Comparison)-336.2(between)-331.7(Patients)-337(Deceased)-336.4(in)-331.6(COVID-)]TJ
/F5 1 Tf
24.3126 0 TD
(19)Tj
/F9 1 Tf
1.336 0 TD
[(in)-331.6(Nursing)-338.2(Homes)]TJ
-25.1879 -1.0077 TD
[(or)-330(in)-337.3(Hospitals)-332.9(for)-332.2(All)-337.8(Registered)-333(Expected)-332.4(Deaths)-335.8(\()]TJ
/F12 1 Tf
24.8596 0 TD
(n)Tj
/F7 1 Tf
.7832 0 TD
(=)Tj
/F5 1 Tf
.7198 0 TD
(390)Tj
/F9 1 Tf
1.4972 0 TD
(\))Tj
/F5 1 Tf
7.3837 0 0 6.5625 444.2455 394.8661 Tm
(a)Tj
/F6 1 Tf
9.845 0 0 9.845 62.022 372.3589 Tm
[(Characteristics)-22241.6(Nursing)-336(homes)-3755.6(Hospitals)]TJ
/F5 1 Tf
47.0876 0 TD
(p)Tj
7.3837 0 0 6.5625 530.5321 376.7243 Tm
(b)Tj
9.845 0 0 9.845 62.022 353.6503 Tm
(Patients,)Tj
/F6 1 Tf
3.7603 0 TD
(N)Tj
/F5 1 Tf
26.9558 0 TD
[(253)-7218.4(137)]TJ
-30.7161 -1.0077 TD
[(Age,)-336.6(mean)-335.7(\(range\))-21701.7(86.6)-334.6(\(63104\))-2967.8(80.9)-334.6(\(47102\))]TJ
/F7 1 Tf
45.2679 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-45.8207 -1.0135 TD
[(Female)-338.9(sex)-332.2(\(%\))-21368.2(139/253)-335.3(\(55\))-3937.1(50/137)-334.3(\(36\))]TJ
/F7 1 Tf
45.2679 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-45.8207 -1.0135 TD
[(Breathlessness)-341.7(\(%\))]TJ
7.3837 0 0 6.5625 138.1039 328.1385 Tm
(c)Tj
9.845 0 0 9.845 340.8944 323.7731 Tm
[(84/240)-334.3(\(35\))-3937.1(89/122)-334.3(\(73\))]TJ
/F7 1 Tf
16.9416 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-44.8187 -1.0135 TD
[(Complete)-335.2(relief)-21465(35/84)-333.4(\(42\))-4438(18/89)-333.4(\(20\))]TJ
/F7 1 Tf
44.2659 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.01)Tj
-44.8187 -1.0077 TD
(Partial)Tj
/F7 1 Tf
2.6259 0 TD
(+)Tj
/F5 1 Tf
.5471 0 TD
[(complete)-341.2(relief)]TJ
7.3837 0 0 6.5625 163.6724 308.2393 Tm
(d)Tj
9.845 0 0 9.845 345.8267 303.8739 Tm
[(80/84)-333.4(\(95\))-4438(82/89)-333.4(\(92\))-3441.8(NS)]TJ
-28.8273 -1.3187 TD
[(Anxiety)-337.5(\(%\))]TJ
7.3837 0 0 6.5625 111.8551 295.2566 Tm
(c)Tj
9.845 0 0 9.845 335.9621 290.8913 Tm
[(131/241)-335.3(\(54\))-3937.1(66/107)-334.3(\(67\))-3441.8(NS)]TJ
-26.8233 -1.0077 TD
[(Complete)-335.2(relief)-20964(96/131)-334.3(\(73\))-4438(35/66)-333.4(\(53\))]TJ
/F7 1 Tf
44.2659 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.01)Tj
-44.8187 -1.0135 TD
(Partial)Tj
/F7 1 Tf
2.6259 0 TD
(+)Tj
/F5 1 Tf
.5471 0 TD
[(complete)-341.2(relief)]TJ
7.3837 0 0 6.5625 163.6724 275.3574 Tm
(d)Tj
9.845 0 0 9.845 335.9621 270.9921 Tm
[(129/131)-335.3(\(98\))-4438(65/66)-333.4(\(98\))-3441.8(NS)]TJ
-27.8253 -1.3187 TD
[(Delirium)-334.1(\(%\))]TJ
7.3837 0 0 6.5625 115.7669 262.4314 Tm
(c)Tj
9.845 0 0 9.845 340.8944 258.0094 Tm
[(38/228)-334.3(\(17\))-3937.1(39/101)-334.3(\(39\))]TJ
/F7 1 Tf
16.9416 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-44.8187 -1.0077 TD
[(Complete)-335.2(relief)-21960.2(7/38)-338.1(\(18\))-4939(6/39)-332.4(\(15\))-3441.8(NS)]TJ
0 -1.0135 TD
(Partial)Tj
/F7 1 Tf
2.6259 0 TD
(+)Tj
/F5 1 Tf
.5471 0 TD
[(complete)-341.2(relief)]TJ
7.3837 0 0 6.5625 163.6724 242.4755 Tm
(d)Tj
9.845 0 0 9.845 345.8267 238.1102 Tm
[(28/38)-333.4(\(74\))-4438(32/39)-333.4(\(82\))-3441.8(NS)]TJ
-28.8273 -1.3187 TD
[(Death)-336.5(rattles)-337.9(\(%\))]TJ
7.3837 0 0 6.5625 131.1307 229.5495 Tm
(c)Tj
9.845 0 0 9.845 335.9621 225.1275 Tm
[(118/248)-335.3(\(48\))-3937.1(60/120)-334.3(\(50\))-3441.8(NS)]TJ
-26.8233 -1.0077 TD
[(Complete)-335.2(relief)-20964(54/118)-334.3(\(46\))-4438(18/60)-333.4(\(30\))-3441.8(NS)-336.6(\(0.053\))]TJ
0 -1.0135 TD
(Partial)Tj
/F7 1 Tf
2.6259 0 TD
(+)Tj
/F5 1 Tf
.5471 0 TD
[(complete)-341.2(relief)]TJ
7.3837 0 0 6.5625 163.6724 209.5937 Tm
(d)Tj
9.845 0 0 9.845 335.9621 205.2283 Tm
[(115/118)-335.3(\(97\))-4438(56/60)-333.4(\(93\))-3441.8(NS)]TJ
-27.8253 -1.313 TD
[(Pain)-333.4(\(%\))]TJ
7.3837 0 0 6.5625 97.6252 196.6676 Tm
(c)Tj
9.845 0 0 9.845 335.9621 192.3023 Tm
[(147/248)-335.3(\(59\))-3937.1(63/120)-334.3(\(53\))-3441.8(NS)]TJ
-26.8233 -1.0135 TD
[(Complete)-335.2(relief)-20463(122/147)-335.3(\(83\))-4438(40/63)-333.4(\(63\))]TJ
/F7 1 Tf
44.2659 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.01)Tj
-44.8187 -1.0135 TD
(Partial)Tj
/F7 1 Tf
2.6259 0 TD
(+)Tj
/F5 1 Tf
.5471 0 TD
[(complete)-341.2(relief)]TJ
7.3837 0 0 6.5625 163.6724 176.7118 Tm
(d)Tj
9.845 0 0 9.845 335.9621 172.3464 Tm
[(147/147)-335.3(\(100\))-3938(62/63)-333.4(\(98\))-3441.8(NS)]TJ
-27.8253 -1.313 TD
[(p.r.n.)-335.6(prescriptions)-337.9(strong)-334.2(opioid)-328.8(\(%\))-12672.8(243/253)-335.3(\(96\))-3436.1(133/137)-335.3(\(97\))-3441.8(NS)]TJ
0 -1.0135 TD
[(p.r.n.)-335.6(prescriptions)-337.9(tranquilizer)-332.8(\(%\))-13432.9(242/253)-335.3(\(96\))-3436.1(134/137)-335.3(\(98\))-3441.8(NS)]TJ
T*
[(p.r.n.)-335.6(prescriptions)-337.9(antiemetic)-333.2(\(%\))-13870.5(238/253)-335.3(\(94\))-3436.1(119/137)-335.3(\(87\))]TJ
/F7 1 Tf
45.2679 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.05)Tj
-45.8207 -1.0135 TD
[(p.r.n.)-335.6(prescriptions)-337.9(antimuscarinic)-337(\(%\))-12148.7(243/253)-335.3(\(96\))-3436.1(127/137)-335.3(\(93\))-3441.8(NS)]TJ
0 -1.0077 TD
[(Parenteral/enteral)-343.4(uids,)-330.6(nutrition)-337.8(during)-334.3(the)-332.6(last)-333.5(day)-338.1(of)-330.2(life)-333.7(\(%\))-1944.6(16/249)-334.3(\(6\))-4437.1(41/130)-334.3(\(32\))]TJ
/F7 1 Tf
45.2679 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
6.5633 0 0 5.8334 70.0157 105.2787 Tm
(a)Tj
8.7511 0 0 8.7511 72.9637 101.4236 Tm
-.0609 Tc
()Tj
/F6 1 Tf
.609 0 TD
0 Tc
[(I)-276(d)0(o)-282.7(not)-273.8(know)]TJ
/F5 1 Tf
5.5584 0 TD
[()54.4()-282.4(was)-276.9(an)-277.4(option)-282(for)-278.7(most)-281.6(questions.)-272.6(Therefore,)-285.5(numbers)-279.1(may)-273.8(not)-280.3(sum)-277.5(to)-281.5(group)-277.8(totals.)-283(The)-278.9()60.9()0(I)-279.8(d)0(o)-282.7(not)-273.8(know)56.8()-282.4(answers)-276.9(are)]TJ
-7.4177 -1.0236 TD
[(analyzed)-337.5(in)-333.3(Table)-334.7(3.)]TJ
6.5633 0 0 5.8334 70.0157 87.3637 Tm
(b)Tj
/F6 1 Tf
8.7511 0 0 8.7511 73.3039 83.5086 Tm
(p)Tj
/F5 1 Tf
.8292 0 TD
[(Values)-338.1(indicate)-333.8(differences)-334.5(between)-333.2(nursing)-330.9(homes)-334.7(and)-334.6(hospitals.)]TJ
/F6 1 Tf
27.2933 0 TD
(p)Tj
/F7 1 Tf
.6673 0 TD
(<)Tj
/F5 1 Tf
.7191 0 TD
[(0.05)-329.6(was)-335.2(considered)-337.4(statistically)-332.6(signicant.)]TJ
6.5633 0 0 5.8334 70.0157 78.4063 Tm
(c)Tj
8.7511 0 0 8.7511 72.9637 74.4944 Tm
[(The)-324.2(question)-324.6(posed)-330.6(was)-328.7()60.9(Did)-331.8(the)-326.8(person)-328(display)-325.8(breakthrough)-327.6(of)-326.6(any)-328.1(of)-326.6(the)-326.8(following)-323.4(symptoms)-324.7(at)-328(any)-328.1(time)-328.4(during)-327.2(the)-326.8(last)-329.3(week)-323.9(of)]TJ
-1.2503 -1.0236 TD
[(life?)55.4()-334.3(Alternatives)-333.5(for)-337(answers)-328.7(on)-334.5(symptom)-334(relief)-333.3(were)-335.4()54.4(Completely,)61()-334.3()54.4(Partially,)56.2()-334.3(and)-328.1()54.4(Not)-331.8(at)-334.5(all.)56.6()]TJ
6.5633 0 0 5.8334 70.0157 60.4913 Tm
(d)Tj
8.7511 0 0 8.7511 73.3039 56.5795 Tm
[(For)-331.8(each)-335.7(symptom,)-330.1()60.9(Complete)-337.7(relief)58()-334.3(i)0(s)-331.7(a)-336.9(subset)-333.1(of)-333.1()54.4(Partial)-329.5(and)-334.6(complete)-332.6(relief.)55.3()]TJ
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(4)Tj
46.8844 0 TD
[(STRANG)-337.5(ET)-338.7(AL.)]TJ
ET
endstream
endobj
47 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 501.0518 Tm
0 0 0 rg
0 Tc
0 Tw
[(symptom)-482.4(to)-486.1(death)-480.3(is)-485.9(only)-476.8(six)-487(days)-477.7(\(mean)-487.1(6.2\))-479(\(personal)]TJ
0 -1.1116 TD
[(communication\))-10.2(,)-470(which)-474.2(is)-474.4(much)-473.3(shorter)-475.3(than)-478(for)-469.8(patients)]TJ
0 -1.1174 TD
[(dying)-414.6(in)-411.3(ICUs.)-412.7(In)-405.3(comparison,)-415.3(Guan)-415.4(et)-412.4(al.)-410.1(report)-411(that)-409(the)]TJ
0 -1.1116 TD
[(median)-292.5(hospital)-286.6(stay)-287.7(\(which)-285.2(was)-287.4(preceded)-289.9(by)-290.2(days)-287.6(with)-287.8(ini-)]TJ
T*
[(tial)-253.6(symptoms\))-259.8(for)-250.9(the)-252.3(severely)-254.1(ill)-257.1(patients)-253.2(in)-250(Wuha)-7.8(n,)-246.4(China)-7.8(,)]TJ
0 -1.1174 TD
[(was)-431.4(13)-428.4(days.)]TJ
7.3823 0 0 6.5614 113.8393 450.6519 Tm
(1)Tj
9.843 0 0 9.843 121.7763 446.2298 Tm
[(If)-428.4(our)-429.5(tentative)-434.4(explanation)-430.7(holds)-431.7(true,)-429.6(ad-)]TJ
-6.3011 -1.1116 TD
[(mission)-239.2(of)]TJ
/F6 1 Tf
4.4177 0 TD
(dying)Tj
/F5 1 Tf
2.4594 0 TD
[(frail)-237.2(elderly)-234.9(to)-232.7(hospitals/ICUs)-237.3(for)-233.6(high-ow)]TJ
-6.8771 -1.1116 TD
[(oxygen)-313(and/or)-307.4(for)-308.5(mechanic)-314.3(ventilator)-307.6(treatment)-314.5(will)-310.9(possi-)]TJ
T*
[(bly)-320.2(prolong)-318.8(the)-315.6(dying)-322.4(process,)-318.3(eventually)-320.2(with)-322.3(more)-317.8(severe)]TJ
0 -1.1174 TD
[(symptoms)-281.7(at)-285.7(the)-281.1(very)-282(EOL)-283(and)-280.9(increased)-285.2(suffering.)]TJ
1.0137 -1.1116 TD
[(From)-408.6(a)-411.2(clinical)-410.2(point)-408.9(of)-411.1(view,)-407.4(the)-407.8(possibility)-415.6(to)-405.5(relieve)]TJ
-1.0137 -1.1116 TD
[(symptoms)-281.7(is)-278.6(as)-273.9(central)-282.1(as)-279.6(the)-275.3(very)-276.2(occurrence)-281.7(of)-278.6(symptoms.)]TJ
0 -1.1174 TD
[(In)-330.5(Swedish)-326.3(health)-331.7(care,)-328.1(the)-327.1(specialized)-334.9(palliative)-331.9(care)-330.4(units)]TJ
0 -1.1116 TD
[(have)-386.9(propagated)-383.2(for)-383.4(evidence-based)-390.9(use)-384.4(of)-382.3()50.8(four)-379.8(essential)]TJ
T*
[(palliative)-228.3(drugs,)47.8()-225.7(needed)-223.2(for)-222.1(quality)-228.1(care)-226.7(of)-221(the)-223.5(dying.)]TJ
7.3823 0 0 6.5614 273.3165 352.0062 Tm
(9)Tj
9.843 0 0 9.843 279.2125 347.6409 Tm
(Such)Tj
-22.2958 -1.1174 TD
[(palliative)-268.6(guidelines)-261.2(have)-260.2(been)-265.9(disseminated)-265.6(both)-258(to)-261.5(nursing)]TJ
0 -1.1116 TD
[(home)-271.7(services)-271.2(and)-269.4(to)-267.3(acute)-268.3(hospitals.)-273.7(As)-267.8(seen)-271.5(from)-264.7(the)-269.5(data,)]TJ
T*
[(these)-336.1(drugs)-333.6(are)-333.9(prescribed)-336.9(to)-330.6(a)-336.3(high)-332.8(extent,)-335.2(both)-332.8(in)-330.6(nursing)]TJ
0 -1.1174 TD
[(homes)-284.2(and)-280.9(in)-278.8(acute)-285.6(hospitals.)]TJ
1.0137 -1.1116 TD
.018 Tc
[(Th)5.4(e)-289.5(p)-.4(ro)5.4(por)5.4(tio)5.4(n)-288.4(o)-.4(f)-288.3()51.5(I)-288.3(do)-288.4(n)5.4(o)-.4(t)-288.5(kno)5.4(w)51.5()-288.3(r)-.3(espo)5.4(nses)-288.2(is)-288.2(of)-288.3(cer-)]TJ
-1.0137 -1.1116 TD
.0126 Tc
[(t)-5.9(a)-6.9(in)-190.1(in)-5.8(t)-5.9(e)-1.2(r)-5.7(e)-6.9(st)-190.2(\()-5.7(T)-1.2(a)-6.9(b)0(l)-5.9(e)-185.5(3)-5.8(\))-5.7(.)-186.7(I)-5.7(n)-184.3(t)-5.9(hi)-5.9(s)-189.9(s).2(t)-5.9(u)-5.8(dy)-5.8(,)-186.7(f)-5.7(or)-190.1(a)-6.9(l)-.1(l)-190.2(c)-1.2(o)-5.8(m)-1.2(p)-5.8(a)-6.9(ri)-5.9(s)-5.6(o)0(n)-5.8(s)-5.6(,)-186.7(t)-5.9(he)]TJ
T*
.0178 Tc
[(pro)5.2(por)5.2(tio)5.2(ns)-346(were)-347.3(hi)5.1(gher)-351.9(i)5.1(n)-346.2(hos)5.4(pit)5.1(a)-1.7(l)5.1(s)-.4(.)-348.5(T)-1.8(h)5.2(i)-.7(s)-346(m)-1.8(ay)-346.2(be)-347.3(du)5.2(e)-347.3(t)-.7(o)]TJ
0 -1.1174 TD
.0173 Tc
[(sev)4.7(e)-2.2(ral)-225.8(r)-1(easo)4.7(ns.)-222.3(T)-2.3(h)4.7(e)-226.9(ELQ)-226.6(i)-1.2(s)-225.5(s)4.9(upp)4.7(osed)-225.7(to)-225.7(b)4.7(e)-226.9(retro)4.7(s)-.9(pecti)4.6(v)-1.1(ely)]TJ
0 -1.1116 TD
.0131 Tc
[(c)-6.4(o)-5.3(mp)-5.3(le)-6.4(t)-5.4(e)-.7(d)-5.3(,)-433.8(ba)-6.4(s)-5.1(e)-.7(d)-431.5(o)-5.3(n)-431.5(d)-5.3(at)-5.4(a)-432.7(f)-5.2(r)-5.2(o).5(m)-432.7(t)-5.4(he)-438.4(me)-6.4(di)-5.4(c)-6.4(a)-.7(l)-431.6(r)-5.2(e)-6.4(c)-.7(o)-5.3(r)-5.2(ds)-5.1(.)-433.8(I).5(n)-5.3(-)]TJ
T*
.0189 Tc
[(suf)6.3().7(ci)6.2(ent)-374(d)6.3(ocu)6.3(m)-.7(e)5.1(n).5(ta)5.1(ti)6.2(on)-373.9(ma)5.1(y)-373.9(r).6(es)6.5(ult)-374(i)6.2(n)-373.9(s).7(ev)6.3(era)5.1(l)-374()52.4().6(I)-373.8(d).5(o)-373.9(n)6.3(ot)]TJ
0 -1.1174 TD
.0178 Tc
[(kno)5.2(w.)51.3()-282.8(An)5.2(oth)5.2(e)-1.7(r)-282.8(r)-.5(easo)5.2(n)-282.8(m)-1.8(i)5.1(ght)-282.9(b)5.2(e)-284(that)-282.9(th)5.2(e)-284(p)-.6(er)5.2(son)-282.8(c)4(omplet-)]TJ
0 -1.1116 TD
.0181 Tc
[(ing)-247.9(t)5.4(he)-249.1(qu)5.5(est)5.4(i)-.4(on)5.5(nai)5.4(r)-.2(e)-249.1(w)-1.1(as)-247.7(not)-248.1(hi)5.4(gh)5.5(ly)-247.9(inv)5.5(o)-.3(l)5.4(v)-.3(ed)-247.9(i)5.4(n)-253.7(t)5.4(h)-.3(e)-249.1(a)-1.4(ctu)5.5(a)-1.4(l)]TJ
T*
.0183 Tc
[(pat)5.6(i)-.2(ent)-322.8(c)4.5(ar)5.7(e.)-319.2(Ho)5.7(wever)5.7(,)-319.2(it)-317(canno)5.7(t)-322.7(b)5.7(e)-323.8(o)5.7(ut)-317(rul)5.6(e)-1.2(d)-316.9(t)-.2(h)5.7(a)-1.2(t)-317(t)-.2(he)-318(di)5.6(f-)]TJ
0 -1.1174 TD
.019 Tc
[(fer)6.4(e)-.5(nc)5.2(es)-350.5(al)6.3(so)-350.7(ma)5.2(y)-356.5(r)6.4(ee)5.2(c)-.5(t)-350.8(t).5(h)6.4(e)-357.6(a)5.2(c)-.5(t)6.3(u).6(al)-350.8(in)6.4(te)5.2(rest)-350.8(i)6.3(n)-356.5(s)6.6(y).6(mp)6.4(to)6.4(ms)]TJ
0 -1.1116 TD
.0182 Tc
[(and)-259.4(s)0(ympto)5.6(m)-266.3(r)5.6(e)-1.3(li)5.5(ef.)-261.7(I)-.1(f)-265.1(s)5.8(ympto)5.6(m)-266.3(co)5.6(nt)5.5(rol)-265.3(a)4.4(nd)-265.1(s)5.8(upp)5.6(ort)-259.5(i)-.3(s)-264.9(t)-.3(h)5.6(e)]TJ
T*
[(main)-357.2(focus)-357(o)-.1(f)-357.1(car)5.7(e)-358.3(i)-.2(n)-357.2(p)-.1(eo)5.7(ple)-358.3(d)5.7(yin)5.7(g)-362.9(f)5.7(r)0(om)-358.4(COVI)5.7(D-1)5.7(9)-.1(,)-359.5(t)5.6(he)]TJ
T*
.0184 Tc
[(pro)5.8(por)5.8(tio)5.8(ns)-299.3(o)5.8(f)-299.4()51.9()5.8(I)-299.4(d)0(o)-293.7(not)-293.9(kno)5.8(w)51.9()-293.7(s).2(ho)5.8(uld)-293.7(b)0(e)-294.9(l)-.1(ow)-294.6(for)-293.7(c)-1.1(entr)5.8(al)]TJ
0 -1.1174 TD
.0188 Tc
[(sym)5(p).4(to)6.2(ms)-275.8(su)6.2(ch)-276(as)-275.8(br)6.2(eat)6.1(hle)5(ssn)6.2(ess)-275.8(a)5(nd)-276(anx)6.2(i).3(e)5(t).3(y.)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 59.7543 127.7858 Tm
0 Tc
[(Strengths)-338.4(and)-331.9(limitations)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 111.3448 Tm
[(One)-477.6(strength)-482.3(of)-474.5(this)-476.8(study)-477.7(is)-474.4(that)-478.1(it)-480.5(is,)-477.9(to)-474.6(best)-477.8(of)-474.5(our)]TJ
-1.0137 -1.1116 TD
[(knowledge,)-362.3(the)-355.9(rst)-361.2(study)-356.8(that)-357.2(actually)-358.3(report)-359.2(data)-358.2(on)-353.5(how)]TJ
T*
[(people)-325.8(are)-328.1(dying,)-325.9(on)-324.7(symptom)-326.9(prevalence)-328(and)-321.2(on)-324.7(symptom)]TJ
0 -1.1174 TD
[(relief.)-196.9(In)-192.2(a)-192.3(PubMed)-192.8(search)-194.2(\(April)-192(24,)-189.9(2020\))-189.8(where)-193(COVID-19)]TJ
0 -1.1116 TD
[(were)-243.7(combined)-248.7(with)-241.7()50.8(palliative,)48.4()-243()50.8(symptom)45.3()-243(and)-240.6()50.8(dying)49.8()]TJ
T*
[(only)-367.4(one)-367.3(article)-362.9(was)-368(identied.)]TJ
7.3823 0 0 6.5614 185.7826 60.9449 Tm
(10)Tj
9.843 0 0 9.843 196.781 56.5795 Tm
[(This)-362.6(article)-368.7(is)-365(about)-363.9(sug-)]TJ
11.5885 67.9242 TD
[(gestions)-315.1(on)-313.2(how)-315.2(palliative)-314.7(care)-318.9(principles)-318.8(can)-316.7(be)-314.4(applied)-315.6(in)]TJ
0 -1.1174 TD
[(the)-499.9(emergency)-499.6(departments,)-504.1(but)-498.8(not)-498.8(on)-497.5(symptoms)-500.6(or)-503.3(on)]TJ
0 -1.1116 TD
[(palliation)-457.5(of)-451.4(symptoms.)-458(The)-454.9(only)-453.8(article)-460.8(we)-453.5(identied)-461.7(as)]TJ
T*
[(regards)-510.9(skilled)-510.2(nursing)-508.7(facilities)-516(focused)-510.9(on)-509(detection)-514.9(of)]TJ
T*
[(COVID-19)-191(and)-188.8(initial)-188.1(symptoms)-189.6(in)-186.6(nursing)-186.2(home)-191.1(residents.)]TJ
7.3823 0 0 6.5614 542.551 685.7006 Tm
(11)Tj
9.843 0 0 9.843 320.8251 670.3369 Tm
[(Another)-361.2(strength)-367.1(is)-365(that)-362.9(we)-367.1(have)-363.8(access)-368(to)-365.2(national)-362.9(data)]TJ
-1.0137 -1.1116 TD
[(from)-454.8(a)-457.3(validated)-457.3(quality)-458.5(register)-460.4(that)-455.1(has)-453.5(been)-456(used)-460.4(as)-452.4(a)]TJ
T*
[(source)-279.4(for)-285.5(30)-278.7(previous)-280.6(peer-reviewed)-286(articles.)]TJ
1.0137 -1.1174 TD
[(Although)-200(the)-200.4(proportions)-202.2(of)-198(deaths)-204.7(reported)-201.3(to)-203.9(the)-200.4(SRPC)-202(is)]TJ
-1.0137 -1.1116 TD
[(acceptable)-283.2(\(60%\),)-280.7(we)-280.7(have)-277.4(no)-278.7(data)-283.3(on)-278.7(the)-275.3(others,)-281.8(which)-278.4(is)-284.4(a)]TJ
T*
[(limitation.)-230.7(Another)-228.7(limitation)-233.1(is)-226.8(that)-230.5(we)-228.9(have)-225.6(relatively)-233.9(more)]TJ
0 -1.1174 TD
[(registrations)-310.5(from)-310.8(nursing)-307.1(homes)-313(than)-305.2(from)-310.8(acute)-308.6(hospitals.)]TJ
0 -1.1116 TD
[(A)-226.6(third)-224.6(limitation)-227.3(is)-226.8(that)-230.5(the)-223.5(ELQ)-231.2(is)-226.8(constructed)-228.8(in)-227(a)-221.1(way)-230(that)]TJ
T*
[(full)-286.9(data)-289.1(are)-287.8(only)-281(reported)-293.4(on)-284.4(patients)-287.8(with)-287.8(expected)-290.1(deaths.)]TJ
T*
[(This)-218.6(means,)-225.4(that)-218.9(we)-223.1(do)-221.1(not)-222.3(have)-219.8(data)-225.7(on)-215.3(the)-223.5(last)-224.5(day\(s\))-220.6(of)-221(life)]TJ
0 -1.1174 TD
[(for)-308.5(those)-311.9(persons)-308(where)-313.9(death)-313.2(was)-310.4(unexpected.)-313(A)-307.2(nal)-310.8(lim-)]TJ
0 -1.1116 TD
[(itation)-435.6(is)-434.1(that)-432(stafng)-440.6(in)-434.3(nursing)-433.8(homes)-433.9(and)-436.4(hospitals)-437.3(are)]TJ
T*
[(different)-415.6(on)-411.1(a)-411.2(group)-414.4(level,)-414.7(with)-414.5(more)-409.9(registered)-417.7(nurses)-416.3(in)]TJ
0 -1.1174 TD
[(hospitals.)-360.1(However,)-360.8(all)-361.8(ELQ)-357.9(were)-364.7(completed)-360.5(by)-359.3(registered)]TJ
0 -1.1116 TD
[(nurses)-232(or)-238.3(\(to)-233.8(a)-232.6(less)-235.7(degree\))-235.8(by)-232.6(physicians,)-235.5(regardless)-238.8(of)-232.6(place)]TJ
T*
[(of)-278.6(care.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 481.8896 Tm
(Conclusions)Tj
/F5 1 Tf
9.843 0 0 9.843 320.8251 465.4487 Tm
[(When)-411(studying)-412.1(all)-413.7(deaths)-412.1(related)-414.6(to)-411.3(COVID-19)-415.6(and)-413.4(re-)]TJ
-1.0137 -1.1174 TD
[(ported)-318.9(to)-313.4(the)-321.4(SRPC,)-320.6(a)-313.3(picture)-321.3(emerges)-323.2(of)-319(persons)-319.5(in)-313.4(a)-319(rela-)]TJ
0 -1.1116 TD
[(tively)-578.4(high)-580.5(age,)-579.3(certainly)-584(different)-582.6(from)-581.5(the)-580.6(reports)-584.7(on)]TJ
T*
[(patients)-449.1(dying)-443.4(at)-447(ICUs.)-447.3(The)-443.4(central)-449.2(and)-448(feared)-447.8(symptom,)]TJ
0 -1.1174 TD
[(breathlessness,)-345.5(is)-342(much)-340.9(less)-345.1(frequent)-345.3(in)-342.1(nursing)-341.7(homes)-341.8(and)]TJ
0 -1.1116 TD
[(when)-369.3(present,)-376.2(it)-371.1(is)-370.8(easier)-372.9(to)-370.9(relieve.)-377.7(Our)-372.8(data)-369.7(indicate)-375.5(that)]TJ
T*
[(these)-290(differences)-293.1(are)-293.6(due)-286.7(to)-290.3(differences)-293.1(between)-294.4(the)-292.6(groups.)]TJ
0 -1.1174 TD
[(Persons)-336.6(residing)-344.1(in)-336.4(Swedish)-343.6(nursing)-341.7(homes)-336(are)-339.7(elderly)-344.3(and)]TJ
0 -1.1116 TD
[(frail)-283.3(and)-286.7(die)-286.8(much)-289(earlier)-287.9(in)-284.5(the)-286.8(course,)-288.6(before)-291.1(severe)-286.3(respi-)]TJ
T*
[(ratory)-278.5(distress)-286.1(develops.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 342.7086 Tm
(Acknowledgments)Tj
/F5 1 Tf
9.843 0 0 9.843 320.8251 326.2676 Tm
[(We)-259.1(thank)-254.5(the)-258(Swedish)-263(Register)-259.9(of)-261.3(Palliative)-256.9(Care)-261.2(\(SRPC\))]TJ
-1.0137 -1.1174 TD
[(for)-337.3(generously)-347.3(providing)-338.4(us)-341.8(with)-339.6(data)-346.7(for)-337.3(the)-344.4(study.)-337.2(Stock-)]TJ
0 -1.1116 TD
[(holm)-432(Sjukhem)-430.5(Foundation)-432.7(is)-428.3(acknowledged)-439.3(for)-429.5(providing)]TJ
T*
[(good)-280.9(facilities)-285.6(in)-278.8(their)-283.4(Research)-285(&)-278.8(Development)-282.9(unit.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 269.2913 Tm
[(Funding)-334.6(information)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 252.8503 Tm
[(This)-523.9(study)-529.6(was)-529.3(supported)-529.4(by)-532.1(the)-528.7(Stockholm)-530.8(Sjukhem)]TJ
-1.0137 -1.1116 TD
[(Foundations)-279.2(Jubilee)-286.6(Fund.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 217.7574 Tm
[(Author)-332.4(Disclosure)-336.7(Statement)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 201.3165 Tm
[(No)-279.5(competing)-284.4(nancial)-283.1(interests)-282.9(exist.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 177.222 Tm
(References)Tj
/F5 1 Tf
9.2951 0 0 9.2951 315.496 161.1779 Tm
[(1.)-500.4(Guan)-366.2(WJ,)-375.9(Ni)-367.2(ZY,)-369.8(Hu)-373.9(Y,)-367.7(et)-369.9(al.:)-369.5(Clinical)-371.9(characteristics)-381.7(of)]TJ
1.2503 -1.1284 TD
[(coronavirus)-427.9(disease)-432.1(2019)-421.4(in)-432.8(China.)-424(N)-428.7(Engl)-428.8(J)-426.2(Med)-424.7(2020.)]TJ
0 -1.1223 TD
[([Epub)-334.3(ahead)-336.6(of)-332(print];)-333.3(DOI:)-334.8(10.1056/NEJMoa2002032)]TJ
-1.2503 -1.1284 TD
[(2.)-500.4(Richardson)-320.5(S,)-320.3(Hirsch)-324.7(JS,)-319.5(Narasimhan)-321(M,)-322.7(et)-321.1(al.:)-320.7(Presenting)]TJ
1.2503 -1.1223 TD
[(characteristics,)-442.8(comorbidities,)-442.1(and)-437.7(outcomes)-434.6(among)-437.5(5700)]TJ
0 -1.1284 TD
[(patients)-257(hospitalized)-261.2(with)-257.2(COVID-19)-259.3(in)-255.9(the)-254.1(New)-257.9(York)-260.6(City)]TJ
0 -1.1223 TD
[(Area.)-336.2(JAMA)-331.5(2020;323:20522059.)]TJ
-1.2503 -1.1284 TD
[(3.)-500.4(Zhou)-276.9(F,)-283.7(Yu)-282.4(T,)-282.7(Du)-282.4(R,)-279.5(et)-278.4(al.:)-284.1(Clinical)-286.5(course)-279.1(and)-285.2(risk)-282(factors)]TJ
1.2503 -1.1223 TD
[(for)-267.3(mortality)-279.6(of)-271(adult)-272.2(inpatients)-275(with)-269.4(COVID-19)-277.6(in)-274.2(Wuhan,)]TJ
0 -1.1284 TD
[(China:)-600.3(A)-605.5(retrospective)-606.3(cohort)-604.6(study.)-597.1(Lancet)-606.4(2020;395:)]TJ
0 -1.1223 TD
(10541062.)Tj
ET
59.754 719.49 239.131 .22668 re
f
59.754 572.428 239.131 .22675 re
f
59.754 690.803 239.131 .28345 re
f
BT
/F9 1 Tf
9.845 0 0 9.845 59.9811 725.1588 Tm
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(3.)Tj
/F9 1 Tf
1.2496 0 TD
[(Proportion)-339.9(of)-331.2()50.8()]TJ
/F12 1 Tf
7.3364 0 TD
[(I)-335(d)0(o)-329.9(not)-338(know)]TJ
/F9 1 Tf
6.605 0 TD
[()50.8(Responses)]TJ
/F6 1 Tf
-18.2143 -2.8562 TD
(Characteristics)Tj
10.5036 1.0135 TD
(Nursing)Tj
.334 -1.0135 TD
[(homes)-2960.9(Hospitals)]TJ
/F5 1 Tf
11.6323 0 TD
(p)Tj
7.3837 0 0 6.5625 285.9023 701.4045 Tm
(a)Tj
9.845 0 0 9.845 59.7543 678.3872 Tm
[(Death)-336.5(was)-338.8(expected)]TJ
.9962 -1.0135 TD
(\(%\))Tj
8.1887 1.0135 TD
[(10/290)-328.6(\(3.4\))-1124.5(17/200)-334.3(\(8.5\))]TJ
/F7 1 Tf
12.3003 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.05)Tj
-22.038 -2.027 TD
[(Breathlessness)-341.7(\(%\))-1455.1(13/253)-328.6(\(5.1\))-1124.5(15/137)-334.3(\(10.9\))]TJ
/F7 1 Tf
21.4851 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.05)Tj
-22.038 -1.0077 TD
[(Anxiety)-337.5(\(%\))-4121.3(12/253)-328.6(\(4.7\))-1124.5(30/137)-334.3(\(10.9\))]TJ
/F7 1 Tf
21.4851 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-22.038 -1.0135 TD
[(Delirium)-339.8(\(%\))-3724(25/253)-328.6(\(9.9\))-1124.5(36/137)-334.3(\(28.5\))]TJ
/F7 1 Tf
21.4851 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-22.038 -1.0135 TD
[(Death)-336.5(rattles)-337.9(\(%\))-2658.7(5/253)-333.4(\(2.0\))-1124.5(17/137)-334.3(\(12.4\))]TJ
/F7 1 Tf
21.4851 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-22.038 -1.0135 TD
[(Pain)-339.1(\(%\))-6062(5/253)-333.4(\(2.0\))-1124.5(17/137)-334.3(\(12.4\))]TJ
/F7 1 Tf
21.4851 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(0.001)Tj
-22.038 -1.0077 TD
(Parenteral/enteral)Tj
.9962 -1.0135 TD
[(uids,)-330.6(nutrition)]TJ
T*
[(during)-328.6(the)-338.3(last)]TJ
T*
[(day)-332.4(of)-330.2(life)-339.5(\(%\))]TJ
8.6839 3.0405 TD
[(4/253)-333.4(\(1.6%\))-792.5(7/137)-333.4(\(5.1%\))-1051.6(NS)]TJ
8.7511 0 0 8.7511 67.748 560.6361 Tm
[(A)-234.3(comparison)-236.6(between)-236.1(patients)-240.3(deceased)-234.6(in)-236.1(COVID-19)-236.7(in)-236.1(nursing)]TJ
-.9134 -1.0301 TD
[(homes)-334.7(or)-333.1(in)-333.3(hospitals.)]TJ
6.5633 0 0 5.8334 67.748 546.5762 Tm
(a)Tj
/F6 1 Tf
8.7511 0 0 8.7511 70.696 542.6644 Tm
(p)Tj
/F5 1 Tf
1.1791 0 TD
[(Values)-681.5(indicate)-677.1(differences)-684.4(between)-683.1(nursing)-674.2(homes)-678(and)]TJ
-2.4294 -1.0236 TD
(hospitals.)Tj
/F6 1 Tf
4.1462 0 TD
(p)Tj
/F7 1 Tf
.6673 0 TD
(<)Tj
/F5 1 Tf
.7191 0 TD
[(0.05)-329.6(was)-335.2(considered)-330.9(statistically)-339.1(signicant.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(SYMPTOM)-340.8(RELIEF)-335.9(IN)-328.8(ELDERLY)-339.4(DYING)-338.9(COVID-19)-330.9(PATIENTS)-25116.1(5)]TJ
ET
endstream
endobj
51 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.2951 0 0 9.2951 66.6708 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(4.)-500.4(Comas-Herrera)-496.6(A,)-489.7(Zalakain)-496.4(J:)-492.9(Mortality)-492.7(associated)-497.2(with)]TJ
1.2503 -1.1223 TD
[(COVID-19)-497.2(outbreaks)-498.5(in)-499.8(care)-497.4(homes:)-497.2(Early)-496.5(international)]TJ
0 -1.1284 TD
[(evidence.)-572.5(2020.)-574(https://ltccovid.org/2020/04/12/mortality-)]TJ
0 -1.1223 TD
.0159 Tc
(associated-with-covid-19-out)Tj
12.1924 0 TD
.0162 Tc
[(breaks)4.8(-)-4.6(in-care-homes-early-)]TJ
-12.1924 -1.1283 TD
.0124 Tc
[(internatio)-6(nal-ev)-6(idence/?fbcli)-5.5(d).1(=IwAR)-4.7(0).1(l4CNr_Zl_nRuG4p)]TJ
0 -1.1223 TD
0 Tc
[(ACEBpu)10.5(xaoT4f50)14.8(VZv6BM)9.9(wBY1GMV32)12.7(f7N6Zzjn)13.8(RWKc)]TJ
0 -1.1284 TD
[(\(Last)-324.8(access)8.5(ed)-333.8(April)-320.6(12,)-329.7(2020\).)]TJ
-1.2503 -1.1223 TD
[(5.)-500.4(Lundstrom)-265.9(S,)-265.4(Axelsson)-266.9(B,)-261.2(Heedman)-271(PA,)-261(et)-266.2(al.:)-265.8(Developing)]TJ
1.2503 -1.1284 TD
[(a)-315.4(national)-312.8(quality)-314.6(register)-317.1(in)-316.9(end-of-life)-317(care:)-313.9(The)-317.6(Swedish)]TJ
0 -1.1223 TD
[(experience.)-335.4(Palliat)-339.4(Med)-333.3(2012;26:313321.)]TJ
-1.2503 -1.1284 TD
[(6.)-500.4(Socialstyrelsen:)-526(National)-515.7(guidelinesTargets)-526(for)-517.4(quality)]TJ
1.2503 -1.1223 TD
[(indicators)-247.4(in)-243.7(palliative)-249.1(care)-247.3(by)-244.3(The)-244.4(Swedish)-246.1(National)-247.3(Board)]TJ
0 -1.1284 TD
[(of)-472.2(Health)-473.2(and)-474.3(Welfare)-479.5([Nationella)-473.3(riktlinjerMa)]TJ
20.5483 .0305 TD
()Tj
.3843 -.0305 TD
(lniva)Tj
1.6224 .0305 TD
()Tj
.3904 -.0305 TD
(er.)Tj
-22.9453 -1.1284 TD
[(Palliativ)-339.1(va)]TJ
4.2573 .0366 TD
()Tj
.3843 -.0366 TD
[(rd)-338.1(i)-341.1(livets)-337.9(slutskede.)-342.3(Ma)]TJ
9.5697 .0366 TD
()Tj
.3904 -.0366 TD
(lniva)Tj
1.6224 .0366 TD
()Tj
.3843 -.0366 TD
[(er)-342.3(fo)]TJ
1.537 .0244 TD
()Tj
.4147 -.0244 TD
[(r)-344(indikatorer])]TJ
-18.56 -1.1223 TD
-.0182 Tc
[(\(Swe\).)-237.8(2)6.1(017.)-237.8(https://www.socialstyrelsen.se/globalassets/share)]TJ
0 -1.1284 TD
-.0193 Tc
[(p)5(o)-1.1(in)5(t-d)5(o)-1.1(k)5(u)-1.1(m)5.4(e).8(nt)5.5(/arti)5.5(k)-1.1(el)5.5(kata)6.9(log)5(/)-.6(n)5(a).8(ti)5.5(on)5(ell)5.5(a).8(-ri)5.5(k)-1.1(t)5.5(lin)5(jer/2)5(0)-1.1(1)5(7)5(-)-3.5(1)5(0)-1.1(-2)5(2)]TJ
0 -1.1223 TD
-.0234 Tc
[(.p)-5.2(df)-336.9(\(L)-7.1(ast)-340.1(a)-3.3(cces)-4.4(s)-4.4(e)-3.3(d)-334.6(A)-.7(p)-5.2(r)-1.5(il)-340.1(26)-5.2(,)-334.5(2).9(0)-5.2(2).9(0)-5.2(\))-1.5(.)]TJ
-1.2503 -1.1284 TD
0 Tc
[(7.)-500.4(Martinsson)-486.2(L,)-483.9(Heedman)-484.4(PA,)-486.7(Lundstrom)-485.5(S,)-478.9(Axelsson)-486.4(B:)]TJ
1.2503 -1.1223 TD
[(Improved)-247.4(data)-246.3(validity)-247(in)-243.7(the)-241.9(Swedish)-246.1(Register)-252.5(of)-240.5(Palliative)]TJ
0 -1.1284 TD
[(Care.)-333.3(PLoS)-337.6(One)-335.6(2017;12:e0186804.)]TJ
-1.2503 -1.1223 TD
-.0242 Tc
[(8)-24.2(.)-524.6(Vandenbrouck)6.2(e)-351.8(JP,)-347.5(von)-347.6(Elm)-353.3(E)4.3(,)-353.6(A)-1.5(ltman)-347.6(DG,)-347.5(et)-347(al.:)-353.1(Strength-)]TJ
1.2503 -1.1284 TD
-.0245 Tc
[(ening)-274.7(t).3(he)-278.9(Report)-5.8(i).3(n)5.9(g)-274.7(of)-277(Observational)-274.1(S)-3.1(tud)5.9(i).3(es)-273.8(in)-274.7(Epidemiology)]TJ
0 -1.1223 TD
-.0241 Tc
[(\(STROBE\):)-285.9(E)4.4(xplan)6.3(ation)-280.4(a)-4(nd)-280.4(el)-5.4(aboratio)6.3(n.)-286.4(Ep)6.3(idemiolo)6.3(gy)-286.5(2007;)]TJ
0 -1.1284 TD
-.0243 Tc
[(18:805)6.1(835.)]TJ
25.7571 25.8851 TD
0 Tc
[(9.)-500.4(Lindqvist)-244.6(O,)-239.7(Lundquist)-239(G,)-239.7(Dickman)-241.8(A,)-239.7(et)-241.8(al.:)-241.4(Four)-237.6(essential)]TJ
1.2503 -1.1223 TD
[(drugs)-301(needed)-306.3(for)-297.8(quality)-302.4(care)-308.3(of)-295.4(the)-302.9(dying:)-304.7(A)-300.6(Delphi-study)]TJ
0 -1.1284 TD
[(based)-282.7(international)-282.3(expert)-279.4(consensus)-281.5(opinion.)-274.4(J)-279.8(Palliat)-278.4(Med)]TJ
0 -1.1223 TD
(2013;16:3843.)Tj
-1.7505 -1.1283 TD
[(10.)-500.5(Hendin)-347.6(A,)-343.4(La)-347.9(Riviere)-344.7(CG,)-342.2(Williscroft)-346.5(DM,)-348.9(et)-339.4(al.:)-345.1(End-of-)]TJ
1.7505 -1.1223 TD
[(life)-390.2(care)-393.7(in)-384(the)-388.3(emergency)-392.1(department)-393(for)-389.3(the)-388.3(patient)-385.9(im-)]TJ
0 -1.1284 TD
[(minently)-363.1(dying)-360(of)-362.5(a)-358.1(highly)-359.6(transmissible)-367.1(acute)-360.4(respiratory)]TJ
0 -1.1223 TD
[(infection)-339.7(\(such)-335.7(as)-333(COVID-19\).)-335(CJEM)-335(2020:14.)]TJ
-1.7505 -1.1284 TD
[(11.)-500.5(Arons)-473.4(MM,)-468.5(Hateld)-470.2(KM,)-470.8(Reddy)-467.2(SC,)-471.6(et)-467.5(al.:)-467.1(Presympto-)]TJ
1.7505 -1.1223 TD
[(matic)-263.7(SARS-CoV-2)-262.5(infections)-265.7(and)-260.8(transmission)-259.6(in)-262(a)-260.5(skilled)]TJ
0 -1.1284 TD
[(nursing)-270.2(facility.)-265.8(N)-264(Engl)-270.3(J)-261.5(Med)-266.2(2020.)-269([Epub)-267.2(ahead)-263.4(of)-264.9(print];)]TJ
0 -1.1223 TD
[(DOI:)-334.8(10.1056/NEJMoa2008457)]TJ
9.843 0 0 9.843 441.014 589.2093 Tm
[(Address)-337.6(correspondence)-337.8(to:)]TJ
/F6 1 Tf
1.5666 -1.1174 TD
[(Peter)-337.3(Strang,)-332.5(MD,)-335.9(PhD)]TJ
-4.8554 -1.1116 TD
[(Department)-337.7(of)-330.6(Oncology-Pathology)]TJ
6.2262 -1.1116 TD
[(Karolinska)-341.4(Institutet)]TJ
-5.8864 -1.1174 TD
[(Stockholm)-341.7(and)-331.6(R)-336.3(&)-330.6(D)-336(Department)]TJ
.9388 -1.1116 TD
[(Stockholms)-336.8(Sjukhem)-339.3(Foundation)]TJ
7.9599 -1.1116 TD
[(P)-336.3(Box)-334(12230)]TJ
-1.9986 -1.1174 TD
[(Stockholm)-335.9(102)-331.6(26)]TJ
4.2795 -1.1116 TD
(Sweden)Tj
-7.8217 -1.7222 TD
(E-mail:)Tj
/F5 1 Tf
3.3925 0 TD
(peter.strang@ki.se)Tj
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(6)Tj
46.8844 0 TD
[(STRANG)-337.5(ET)-338.7(AL.)]TJ
ET
endstream
endobj
62 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
64 0 obj
<>stream
htVTg? \塂(W 32p_1<4>V*z[$He]kZwk9쳿o_%J5,&jv"rMU<%<~WN2jofV{fvKƲtnl.xJ e( ]D)Ũ[`ڌ+RMbtnjȫ9F[FAat6!`Y32f."ZgJ`2RiK:1A%FT #a AR *!L"܄", BJ(?9@o!JX$[@Q]Wu_.V;ho]&wJ$'ש>Csi3}:ϵcf&[sP07GcZX$"cȜx;`DZ(_i&[hO]]ᠽ{Zp_ķ M:
DxzQח@ЕG!c+z$~_{ܻX/'%u?qK"Y$wB528D3^Dvx'[~F'%kNmW텾JX88:@#a0j2eK>e
9$Nö7s.wDH<B
cAa^[q(jR/G)Dj
Mef
4jÀ1ha6k58*N\Й39ң0
vb\q/3iXʵ 8ENaU[s"gxm7㰌YQ|yϢ ?^&PTb"J^ٜ=-ܲgavᾮWvvkޯ\^h7~$@,gd~i}bHnCk[5d
ףi[yNAegyO~.繧>hfX0S634ϯ
ϋd2v
f%(D*hB0Hm88tqD_=.SGt*lðmzh;tnü|튬btzZkT:>e_wa5-Gj^Y#)3W*ζcmĘ~,$]vu߰S=%,_xlskV186q92X𢄌D8Ѳ.-:yՁk_laތ-Mh
Zt?p\e*0 0Xgwrmb_R:I =XT0C71i}3!vyM`v`nU˾:iO͋aWr9 $sV1$e\Rѭ{ ?Ni~
/hZ]$/F^x
ĎcSٓ܌S5ߑ QVu@HafPmdC>#.%Qjʨ)6S?ֱ-Mr)xL'-8P$AbIriX+°}ˮ7DM} +UJ]$F˛=d9:cZuh#7vo}-|!m
]9P$ݕH*ܶ1TàA.MxS5ZJ_y{te[yki,0~~Etuo1|6gӉ"ה+I+9Zz`ľ[fT7Coށ>(06ޓS~2[W]&Q 'Qro4
*_t
LH0+
ÆKx\psTjcI9oQ\(f-LMw+["d01qanfzkLs
٠Mě Vo_uKSeWc*[QH@R+tfx'U7(G-^TZor6mC+fd_tt^$+䤝pS)|@3}dN@磜),y*B1{H}Lxy! E1h`V?k
S2DLvS;:7קӊ7Yc-)S_nă $T:'MϤl%^HTِ_p9\9ڼ|yȾ1 yc
endstream
endobj
66 0 obj
<>stream
hl_LSg!|g_7mHGB9w͛l#l uɲB9?I[]̸@YeKvaX&.Yv77y^x.yee_ok~:){Z|Ύ6Y+hjwе셟ue/7ysGwwo5:`6ڸ].vTQiK_W*NGT.rNN$*uRtIh%j:\oz*{@*d"K ?43mq`>b6*02YvdW`O/[)009[4G|L\ML